SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Janus Henderson Group PLC – ‘10-Q’ for 3/31/20

On:  Thursday, 4/30/20, at 6:16am ET   ·   For:  3/31/20   ·   Accession #:  1558370-20-4715   ·   File #:  1-38103

Previous ‘10-Q’:  ‘10-Q’ on 10/30/19 for 9/30/19   ·   Next:  ‘10-Q’ on 7/29/20 for 6/30/20   ·   Latest:  ‘10-Q’ on 5/2/24 for 3/31/24   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/30/20  Janus Henderson Group PLC         10-Q        3/31/20   72:9.8M                                   Toppan Merrill Bridge/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.32M 
 2: EX-15.1     Letter re: Unaudited Interim Financial Info         HTML     22K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     23K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     23K 
12: R1          Document and Entity Information                     HTML     76K 
51: R2          Consolidated Balance Sheets                         HTML    125K 
58: R3          Consolidated Balance Sheets (Parenthetical)         HTML     33K 
38: R4          Consolidated Statements of Comprehensive Income     HTML    130K 
                (Loss)                                                           
15: R5          Consolidated Statements of Cash Flows               HTML    130K 
54: R6          Consolidated Statements of Changes in Equity        HTML     62K 
61: R7          Basis of Presentation and Significant Accounting    HTML     28K 
                Policies                                                         
35: R8          Dispositions                                        HTML     34K 
16: R9          Consolidation                                       HTML     44K 
27: R10         Investment Securities                               HTML    138K 
32: R11         Fair Value Measurements                             HTML    294K 
68: R12         Goodwill and Intangible Assets                      HTML    146K 
45: R13         Debt                                                HTML     42K 
28: R14         Income Taxes                                        HTML     35K 
33: R15         Noncontrolling Interests                            HTML     70K 
69: R16         Long-Term Incentive Compensation                    HTML     23K 
46: R17         Retirement Benefit Plans                            HTML     38K 
26: R18         Accumulated Other Comprehensive Loss                HTML     91K 
34: R19         Earnings (Loss) and Dividends Per Share             HTML     68K 
59: R20         Commitments and Contingencies                       HTML     32K 
52: R21         Basis of Presentation and Significant Accounting    HTML     31K 
                Policies (Policies)                                              
13: R22         Dispositions (Tables)                               HTML     38K 
36: R23         Consolidation (Tables)                              HTML     40K 
60: R24         Investment Securities (Tables)                      HTML    144K 
53: R25         Fair Value Measurements (Tables)                    HTML    294K 
14: R26         Goodwill and Intangible Assets (Tables)             HTML    146K 
37: R27         Debt (Tables)                                       HTML     43K 
62: R28         Income Taxes (Tables)                               HTML     30K 
50: R29         Noncontrolling Interests (Tables)                   HTML     71K 
48: R30         Retirement Benefit Plans (Tables)                   HTML     38K 
72: R31         Accumulated Other Comprehensive Loss (Tables)       HTML     93K 
31: R32         Earnings (Loss) and Dividends Per Share (Tables)    HTML     72K 
25: R33         Basis of Presentation and Significant Accounting    HTML     24K 
                Policies (Details)                                               
47: R34         Dispositions (Details)                              HTML     39K 
71: R35         Dispositions - Gain on Sale (Details)               HTML     46K 
30: R36         Consolidation - VIEs (Details)                      HTML     22K 
24: R37         Consolidation - VREs (Details)                      HTML     39K 
49: R38         Investment Securities - General Disclosure          HTML     98K 
                (Details)                                                        
70: R39         Investment Securities - Offsetting Derivatives      HTML     83K 
                (Details)                                                        
56: R40         Fair Value Measurements - Level of Fair Value       HTML    123K 
                (Details)                                                        
65: R41         Fair Value Measurements - Valuation techniques and  HTML     38K 
                significant unobservable inputs (Details)                        
42: R42         Fair Value Measurements - Contingent Consideration  HTML     25K 
                (Details)                                                        
19: R43         Fair Value Measurements - Disposal of Geneva        HTML     34K 
                (Details)                                                        
55: R44         Fair Value Measurements - Acquisition of Kapstream  HTML     39K 
                (Details)                                                        
64: R45         Fair Value Measurements - Disposal of Volantis      HTML     35K 
                (Details)                                                        
41: R46         Fair Value Measurements - Level 3 Rollforward       HTML     72K 
                (Details)                                                        
17: R47         Goodwill and Intangible Assets (Details)            HTML    122K 
57: R48         Debt (Details)                                      HTML     49K 
63: R49         Income Taxes (Details)                              HTML     51K 
66: R50         Noncontrolling Interests - Redeemable (Details)     HTML     52K 
43: R51         Noncontrolling Interests - Nonredeemable (Details)  HTML     28K 
22: R52         Long-Term Incentive and Employee Compensation       HTML     29K 
                (Details)                                                        
29: R53         Retirement benefit plans - Actuarial                HTML     35K 
                gains(Losses), Benefit Cost, Cash Flows (Details)                
67: R54         Accumulated Other Comprehensive Loss (Details)      HTML     42K 
44: R55         Accumulated Other Comprehensive Loss - OCI          HTML     38K 
                (Details)                                                        
23: R56         Earnings (Loss) and Dividends Per Share (Details)   HTML     56K 
39: XML         IDEA XML File -- Filing Summary                      XML    126K 
18: XML         XBRL Instance -- jhg-20200430x10q_htm                XML   2.64M 
20: EXCEL       IDEA Workbook of Financial Reports                  XLSX     71K 
 8: EX-101.CAL  XBRL Calculations -- jhg-20200430_cal                XML    177K 
 9: EX-101.DEF  XBRL Definitions -- jhg-20200430_def                 XML    777K 
10: EX-101.LAB  XBRL Labels -- jhg-20200430_lab                      XML   1.32M 
11: EX-101.PRE  XBRL Presentations -- jhg-20200430_pre               XML   1.02M 
 7: EX-101.SCH  XBRL Schema -- jhg-20200430                          XSD    169K 
21: JSON        XBRL Instance as JSON Data -- MetaLinks              328±   508K 
40: ZIP         XBRL Zipped Folder -- 0001558370-20-004715-xbrl      Zip    285K 


‘10-Q’   —   Quarterly Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:   C:   C:   C:   C: 
 i  i  i P3Y i P1Y i 0001274173 i --12-31 i 2020 i Q1 i false i 184914488 i 186975693 i P5Y i 0 i 00001274173us-gaap:CommonStockMember2020-01-012020-03-310001274173us-gaap:CommonStockMember2019-01-012019-03-310001274173us-gaap:TreasuryStockMember2020-03-310001274173us-gaap:RetainedEarningsMember2020-03-310001274173us-gaap:NoncontrollingInterestMember2020-03-310001274173us-gaap:AdditionalPaidInCapitalMember2020-03-310001274173us-gaap:TreasuryStockMember2019-12-310001274173us-gaap:RetainedEarningsMember2019-12-310001274173us-gaap:NoncontrollingInterestMember2019-12-310001274173us-gaap:AdditionalPaidInCapitalMember2019-12-310001274173us-gaap:TreasuryStockMember2019-03-310001274173us-gaap:RetainedEarningsMember2019-03-310001274173us-gaap:NoncontrollingInterestMember2019-03-310001274173us-gaap:AdditionalPaidInCapitalMember2019-03-310001274173us-gaap:TreasuryStockMember2018-12-310001274173us-gaap:RetainedEarningsMember2018-12-310001274173us-gaap:NoncontrollingInterestMember2018-12-310001274173us-gaap:AdditionalPaidInCapitalMember2018-12-310001274173us-gaap:AccumulatedTranslationAdjustmentMember2020-03-310001274173us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310001274173us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-03-310001274173us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310001274173us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001274173us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-310001274173us-gaap:AccumulatedTranslationAdjustmentMember2019-03-310001274173us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-03-310001274173us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-03-310001274173us-gaap:AccumulatedTranslationAdjustmentMember2018-12-310001274173us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310001274173us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-12-310001274173srt:MinimumMember2020-01-012020-03-310001274173srt:MaximumMember2020-01-012020-03-310001274173us-gaap:NondesignatedMember2020-01-012020-03-310001274173us-gaap:ShareholderServiceMember2020-01-012020-03-310001274173us-gaap:ProductAndServiceOtherMember2020-01-012020-03-310001274173us-gaap:InvestmentPerformanceMember2020-01-012020-03-310001274173us-gaap:InvestmentAdviceMember2020-01-012020-03-310001274173us-gaap:ShareholderServiceMember2019-01-012019-03-310001274173us-gaap:ProductAndServiceOtherMember2019-01-012019-03-310001274173us-gaap:InvestmentPerformanceMember2019-01-012019-03-310001274173us-gaap:InvestmentAdviceMember2019-01-012019-03-310001274173us-gaap:ConsolidatedEntitiesMemberjhg:SeededInvestmentProductsMember2020-03-310001274173us-gaap:ConsolidatedEntitiesMemberjhg:SeededInvestmentProductsMember2019-12-310001274173jhg:IntechFoundersMember2019-12-310001274173jhg:SeededInvestmentProductsMember2019-03-310001274173jhg:SeededInvestmentProductsMember2018-12-3100012741732020-03-052020-03-050001274173jhg:KapstreamCapitalPtyLimitedMember2020-02-012020-02-290001274173jhg:KapstreamCapitalPtyLimitedMember2019-02-012019-02-280001274173jhg:KapstreamCapitalPtyLimitedMember2018-02-012018-02-280001274173us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-03-310001274173us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-03-310001274173us-gaap:AccumulatedTranslationAdjustmentMember2019-01-012019-03-310001274173srt:SubsidiariesMember2020-03-310001274173srt:SubsidiariesMember2019-12-310001274173jhg:SeniorNotes4.875PercentDue2025Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-03-310001274173jhg:SeniorNotes4.875PercentDue2025Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-03-310001274173jhg:SeniorNotes4.875PercentDue2025Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2019-12-310001274173jhg:SeniorNotes4.875PercentDue2025Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2019-12-310001274173jhg:UnsecuredRevolvingCreditFacilityMember2020-03-310001274173us-gaap:ShortTermInvestmentsMemberus-gaap:OtherInvestmentsMember2020-03-310001274173us-gaap:ShortTermInvestmentsMemberjhg:DeferredCompensationHedgeAssetMember2020-03-310001274173us-gaap:ShortTermInvestmentsMemberus-gaap:OtherInvestmentsMember2019-12-310001274173us-gaap:ShortTermInvestmentsMemberjhg:DeferredCompensationHedgeAssetMember2019-12-310001274173jhg:InvestmentManagementAgreementsMember2019-01-012019-03-310001274173us-gaap:TrademarksMember2020-03-310001274173jhg:InvestmentManagementAgreementsMember2020-03-310001274173us-gaap:TrademarksMember2019-12-310001274173jhg:InvestmentManagementAgreementsMember2019-12-310001274173us-gaap:TrademarksMember2019-03-310001274173jhg:InvestmentManagementAgreementsMember2019-03-310001274173us-gaap:TrademarksMember2018-12-310001274173jhg:InvestmentManagementAgreementsMember2018-12-310001274173srt:MinimumMembercountry:GBsrt:ScenarioForecastMember2020-04-012020-06-300001274173srt:MaximumMembercountry:GBsrt:ScenarioForecastMember2020-04-012020-06-300001274173us-gaap:TrademarksMember2020-03-012020-03-310001274173jhg:InvestmentManagementAgreementsMember2020-03-012020-03-310001274173us-gaap:TrademarksMember2020-01-012020-03-310001274173jhg:InvestmentManagementAgreementsMember2020-01-012020-03-310001274173us-gaap:CustomerRelationshipsMember2020-03-012020-03-310001274173jhg:GenevaCapitalManagementMember2020-01-012020-03-310001274173us-gaap:OtherInvestmentsMember2020-01-012020-03-310001274173jhg:SeededInvestmentProductsAndDerivativesMember2020-01-012020-03-310001274173us-gaap:OtherInvestmentsMember2019-01-012019-03-310001274173jhg:SeededInvestmentProductsAndDerivativesMember2019-01-012019-03-310001274173us-gaap:CustomerRelationshipsMember2020-03-310001274173us-gaap:CustomerRelationshipsMember2019-12-310001274173us-gaap:CustomerRelationshipsMember2019-03-310001274173us-gaap:CustomerRelationshipsMember2018-12-310001274173us-gaap:CustomerRelationshipsMember2020-01-012020-03-310001274173us-gaap:DeferredBonusMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-03-310001274173us-gaap:DeferredBonusMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001274173jhg:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001274173us-gaap:DeferredBonusMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2019-03-310001274173jhg:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2019-03-310001274173us-gaap:DeferredBonusMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2018-12-310001274173jhg:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2018-12-310001274173country:GBsrt:ScenarioForecastMember2020-06-302020-06-300001274173country:GB2020-04-012020-04-010001274173country:GB2020-03-012020-03-310001274173country:GB2020-01-012020-03-310001274173us-gaap:TotalReturnSwapMemberjhg:DerivativeInstrumentsMemberjhg:SeededInvestmentProductsMember2020-03-310001274173us-gaap:InterestRateSwapMemberjhg:DerivativeInstrumentsMemberjhg:SeededInvestmentProductsMember2020-03-310001274173us-gaap:FutureMemberjhg:DerivativeInstrumentsMemberus-gaap:NondesignatedMember2020-03-310001274173us-gaap:FutureMemberjhg:DerivativeInstrumentsMemberjhg:SeededInvestmentProductsMember2020-03-310001274173us-gaap:ForeignExchangeForwardMemberjhg:DerivativeInstrumentsMemberus-gaap:NondesignatedMember2020-03-310001274173us-gaap:ForeignExchangeForwardMemberjhg:DerivativeInstrumentsMemberjhg:SeededInvestmentProductsMember2020-03-310001274173us-gaap:CreditDefaultSwapMemberjhg:DerivativeInstrumentsMemberus-gaap:NondesignatedMember2020-03-310001274173us-gaap:CreditDefaultSwapMemberjhg:DerivativeInstrumentsMemberjhg:SeededInvestmentProductsMember2020-03-310001274173us-gaap:ConsolidatedEntitiesMemberus-gaap:CreditDefaultSwapSellingProtectionMemberjhg:SeededInvestmentProductsMember2020-03-310001274173jhg:TotalReturnSwapsAndIndexSwapsMemberjhg:DerivativeInstrumentsMemberus-gaap:NondesignatedMember2020-03-310001274173jhg:ContractsForDifferencesMemberjhg:DerivativeInstrumentsMemberjhg:SeededInvestmentProductsMember2020-03-310001274173us-gaap:TotalReturnSwapMemberjhg:DerivativeInstrumentsMemberjhg:SeededInvestmentProductsMember2019-12-310001274173us-gaap:PutOptionMemberjhg:DerivativeInstrumentsMemberjhg:SeededInvestmentProductsMember2019-12-310001274173us-gaap:InterestRateSwapMemberjhg:DerivativeInstrumentsMemberjhg:SeededInvestmentProductsMember2019-12-310001274173us-gaap:FutureMemberjhg:DerivativeInstrumentsMemberus-gaap:NondesignatedMember2019-12-310001274173us-gaap:FutureMemberjhg:DerivativeInstrumentsMemberjhg:SeededInvestmentProductsMember2019-12-310001274173us-gaap:ForeignExchangeForwardMemberjhg:DerivativeInstrumentsMemberus-gaap:NondesignatedMember2019-12-310001274173us-gaap:ForeignExchangeForwardMemberjhg:DerivativeInstrumentsMemberjhg:SeededInvestmentProductsMember2019-12-310001274173us-gaap:CreditDefaultSwapMemberjhg:DerivativeInstrumentsMemberus-gaap:NondesignatedMember2019-12-310001274173us-gaap:CreditDefaultSwapMemberjhg:DerivativeInstrumentsMemberjhg:SeededInvestmentProductsMember2019-12-310001274173jhg:TotalReturnSwapsAndIndexSwapsMemberjhg:DerivativeInstrumentsMemberus-gaap:NondesignatedMember2019-12-310001274173jhg:ContractsForDifferencesMemberjhg:DerivativeInstrumentsMemberjhg:SeededInvestmentProductsMember2019-12-310001274173us-gaap:ConsolidatedEntitiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberjhg:SeededInvestmentProductsMember2020-03-310001274173us-gaap:ConsolidatedEntitiesMemberus-gaap:FairValueMeasurementsRecurringMemberjhg:SeededInvestmentProductsMember2020-03-310001274173jhg:DeferredBonusesHedgeLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-03-310001274173jhg:DeferredBonusesHedgeLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2020-03-310001274173us-gaap:ConsolidatedEntitiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberjhg:SeededInvestmentProductsMember2019-12-310001274173us-gaap:ConsolidatedEntitiesMemberus-gaap:FairValueMeasurementsRecurringMemberjhg:SeededInvestmentProductsMember2019-12-310001274173us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberjhg:SeededHedgeDerivatesMember2020-03-310001274173us-gaap:FairValueMeasurementsRecurringMemberjhg:SeededHedgeDerivatesMember2020-03-310001274173us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberjhg:SeededHedgeDerivatesMember2019-12-310001274173us-gaap:FairValueMeasurementsRecurringMemberjhg:SeededHedgeDerivatesMember2019-12-310001274173jhg:SeniorNotes4.875PercentDue2025Member2020-03-310001274173us-gaap:ConsolidatedEntitiesMemberus-gaap:CreditDefaultSwapSellingProtectionMemberjhg:SeededInvestmentProductsMember2019-12-310001274173us-gaap:ConsolidatedEntitiesMembersrt:MinimumMemberus-gaap:CreditDefaultSwapSellingProtectionMemberjhg:SeededInvestmentProductsMember2020-01-012020-03-310001274173us-gaap:ConsolidatedEntitiesMembersrt:MaximumMemberus-gaap:CreditDefaultSwapSellingProtectionMemberjhg:SeededInvestmentProductsMember2020-01-012020-03-310001274173us-gaap:CommonStockMember2020-03-310001274173us-gaap:CommonStockMember2019-12-310001274173us-gaap:CommonStockMember2019-03-310001274173us-gaap:CommonStockMember2018-12-3100012741732020-04-292020-04-2900012741732020-02-032020-02-030001274173us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2019-03-310001274173srt:ConsolidatedEntityExcludingVariableInterestEntitiesVIEMember2019-03-3100012741732019-03-3100012741732018-12-310001274173us-gaap:AccountingStandardsUpdate201815Member2020-01-012020-03-310001274173jhg:KapstreamCapitalPtyLimitedMember2020-03-310001274173jhg:GenevaCapitalManagementMember2020-03-310001274173srt:MaximumMemberjhg:KapstreamCapitalPtyLimitedMember2017-01-310001274173us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberjhg:VolantisMember2020-03-310001274173us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberjhg:GenevaCapitalManagementMember2020-03-310001274173us-gaap:FairValueMeasurementsRecurringMemberjhg:VolantisMember2020-03-310001274173us-gaap:FairValueMeasurementsRecurringMemberjhg:GenevaCapitalManagementMember2020-03-310001274173us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberjhg:VolantisMember2020-03-310001274173srt:MinimumMemberjhg:GenevaCapitalManagementMember2020-03-170001274173srt:MaximumMemberjhg:GenevaCapitalManagementMember2020-03-170001274173us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberjhg:VolantisMember2019-12-310001274173us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-03-310001274173us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2020-03-310001274173us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2020-03-310001274173us-gaap:FairValueMeasurementsRecurringMember2020-03-310001274173us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001274173us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001274173us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001274173us-gaap:FairValueMeasurementsRecurringMember2019-12-310001274173jhg:RestrictedStockAndUnvestedNonparticipatingStockAwardMember2020-01-012020-03-310001274173jhg:RestrictedStockAndUnvestedNonparticipatingStockAwardMember2019-01-012019-03-310001274173us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberjhg:DiscountedCashFlowMethodMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMember2020-03-310001274173us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberjhg:DiscountedCashFlowMethodMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMember2019-12-310001274173us-gaap:TreasuryStockMember2020-01-012020-03-310001274173us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310001274173us-gaap:TreasuryStockMember2019-01-012019-03-310001274173us-gaap:AdditionalPaidInCapitalMember2019-01-012019-03-310001274173us-gaap:ConsolidatedEntitiesMemberus-gaap:ShortTermInvestmentsMemberjhg:SeededInvestmentProductsMember2020-01-012020-03-310001274173us-gaap:ShortTermInvestmentsMember2020-01-012020-03-310001274173us-gaap:ConsolidatedEntitiesMemberus-gaap:ShortTermInvestmentsMemberjhg:SeededInvestmentProductsMember2019-01-012019-03-310001274173us-gaap:ShortTermInvestmentsMember2019-01-012019-03-310001274173jhg:GenevaCapitalManagementMember2020-03-172020-03-170001274173jhg:VolantisMember2017-04-012017-04-0100012741732020-03-272020-03-270001274173jhg:GenevaCapitalManagementMember2020-03-170001274173us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-310001274173us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-03-310001274173jhg:KapstreamCapitalPtyLimitedMember2017-01-310001274173us-gaap:RetainedEarningsMember2020-01-012020-03-310001274173us-gaap:NoncontrollingInterestMember2020-01-012020-03-310001274173us-gaap:RetainedEarningsMember2019-01-012019-03-310001274173us-gaap:NoncontrollingInterestMember2019-01-012019-03-310001274173jhg:IntechFoundersMember2020-03-310001274173jhg:SeededInvestmentProductsMember2020-01-012020-03-310001274173jhg:SeededInvestmentProductsMember2019-01-012019-03-310001274173us-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMember2020-03-310001274173us-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMember2020-03-310001274173us-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMember2020-03-310001274173us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryAggregatedDisclosureMember2020-03-310001274173us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryAggregatedDisclosureMember2020-03-310001274173us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-03-310001274173us-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMember2020-03-310001274173us-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryAggregatedDisclosureMember2020-03-310001274173us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMember2020-03-310001274173us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMember2020-03-310001274173us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMember2020-03-310001274173us-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMember2020-03-310001274173us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2020-03-310001274173us-gaap:VariableInterestEntityNotPrimaryBeneficiaryAggregatedDisclosureMember2020-03-310001274173srt:ConsolidatedEntityExcludingVariableInterestEntitiesVIEMember2020-03-310001274173jhg:VariableRightsEntityPrimaryBeneficiaryAggregatedDisclosureMember2020-03-310001274173jhg:VariableRightsEntityNotPrimaryBeneficiaryAggregatedDisclosureMember2020-03-310001274173us-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMember2019-12-310001274173us-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMember2019-12-310001274173us-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMember2019-12-310001274173us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryAggregatedDisclosureMember2019-12-310001274173us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryAggregatedDisclosureMember2019-12-310001274173us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001274173us-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMember2019-12-310001274173us-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryAggregatedDisclosureMember2019-12-310001274173us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMember2019-12-310001274173us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMember2019-12-310001274173us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMember2019-12-310001274173us-gaap:FairValueMeasurementsRecurringMemberus-gaap:SecuritiesInvestmentMember2019-12-310001274173us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2019-12-310001274173us-gaap:VariableInterestEntityNotPrimaryBeneficiaryAggregatedDisclosureMember2019-12-310001274173srt:ConsolidatedEntityExcludingVariableInterestEntitiesVIEMember2019-12-310001274173jhg:VariableRightsEntityPrimaryBeneficiaryAggregatedDisclosureMember2019-12-310001274173jhg:VariableRightsEntityNotPrimaryBeneficiaryAggregatedDisclosureMember2019-12-310001274173jhg:DeferredBonusesHedgeLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001274173jhg:DeferredBonusesHedgeLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001274173jhg:UnsecuredRevolvingCreditFacilityMember2020-01-012020-03-310001274173us-gaap:ShortTermInvestmentsMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMember2020-03-310001274173us-gaap:ShortTermInvestmentsMemberjhg:VotingRightsEntityPrimaryBeneficiaryAggregatedDisclosureMember2020-03-310001274173us-gaap:ShortTermInvestmentsMemberjhg:SeparatelyManagedAccountsMember2020-03-310001274173us-gaap:ShortTermInvestmentsMemberjhg:PooledInvestmentFundsMember2020-03-310001274173us-gaap:EquityMethodInvesteeMemberus-gaap:ShortTermInvestmentsMember2020-03-310001274173jhg:SeededInvestmentProductsMember2020-03-310001274173us-gaap:ShortTermInvestmentsMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMember2019-12-310001274173us-gaap:ShortTermInvestmentsMemberjhg:VotingRightsEntityPrimaryBeneficiaryAggregatedDisclosureMember2019-12-310001274173us-gaap:ShortTermInvestmentsMemberjhg:SeparatelyManagedAccountsMember2019-12-310001274173us-gaap:ShortTermInvestmentsMemberjhg:PooledInvestmentFundsMember2019-12-310001274173us-gaap:EquityMethodInvesteeMemberus-gaap:ShortTermInvestmentsMember2019-12-310001274173jhg:SeededInvestmentProductsMember2019-12-310001274173jhg:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2019-01-012019-03-310001274173us-gaap:DeferredBonusMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-01-012020-03-310001274173jhg:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-01-012020-03-310001274173us-gaap:DeferredBonusMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2019-01-012019-03-310001274173us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberjhg:DiscountedCashFlowMethodMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMember2020-01-012020-03-310001274173us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberjhg:DiscountedCashFlowMethodMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMember2019-01-012019-12-3100012741732019-12-310001274173us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberjhg:VolantisMember2017-04-012017-04-0100012741732020-03-310001274173jhg:IntechMembersrt:SubsidiariesMember2020-01-012020-03-310001274173jhg:IntechMembersrt:SubsidiariesMember2019-01-012019-12-3100012741732019-01-012019-03-3100012741732020-04-2700012741732020-01-012020-03-31xbrli:sharesiso4217:USDxbrli:purejhg:itemiso4217:USDxbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM  i 10-Q

 i  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended  i March 31, 2020

OR

 i  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

for the transition period from to

Commission File Number  i 001-38103

Graphic

 i JANUS HENDERSON GROUP PLC

(Exact name of registrant as specified in its charter)

 i Jersey, Channel Islands
(State or other jurisdiction of
incorporation or organization)

 i 98-1376360
(I.R.S. Employer
Identification No.)

 i 201 Bishopsgate

 i London,  i United Kingdom
(Address of principal executive offices)

 i EC2M3AE
(Zip Code)

 i +44  i (0) 20  i 7818 1818

(Registrant’s telephone number, including area code)

N/A
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

 i Common Stock, $1.50 Per Share Par Value

 i JHG

 i New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Company was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days.  i Yes  No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  i Yes  No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 i Large Accelerated Filer Accelerated Filer Non-Accelerated Filer Smaller Reporting Company  i  Emerging Growth Company  i 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  i  No 

As of April 27, 2020, there were  i 184,914,488 shares of the Company’s common stock, $1.50 par value per share, issued and outstanding.

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements

JANUS HENDERSON GROUP PLC

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(U.S. Dollars in Millions, Except Share Data)

March 31, 

December 31, 

    

2020

    

2019

ASSETS

Current assets:

Cash and cash equivalents

$

 i 732.5

$

 i 733.9

Investment securities

 

 i 250.6

 

 i 253.5

Fees and other receivables

 

 i 291.3

 

 i 334.8

OEIC and unit trust receivables

 

 i 206.2

 

 i 131.7

Assets of consolidated VIEs:

Cash and cash equivalents

 i 69.7

 i 62.6

Investment securities

 i 548.8

 i 924.8

Other current assets

 i 35.0

 i 23.5

Other current assets

 i 110.4

 i 116.0

Total current assets

 

 i 2,244.5

 

 i 2,580.8

Non-current assets:

Property, equipment and software, net

 

 i 84.0

 

 i 84.7

Intangible assets, net

 

 i 2,651.7

 

 i 3,088.6

Goodwill

 

 i 1,307.1

 

 i 1,504.3

Retirement benefit asset, net

 i 200.3

 i 214.0

Other non-current assets

 

 i 156.3

 

 i 149.3

Total assets

$

 i 6,643.9

$

 i 7,621.7

LIABILITIES

Current liabilities:

Accounts payable and accrued liabilities

$

 i 221.6

$

 i 246.0

Current portion of accrued compensation, benefits and staff costs

 

 i 172.3

 

 i 335.7

OEIC and unit trust payables

 i 213.7

 i 130.9

Liabilities of consolidated VIEs:

Accounts payable and accrued liabilities

 

 i 83.1

 

 i 57.1

Total current liabilities

 

 i 690.7

 

 i 769.7

Non-current liabilities:

Accrued compensation, benefits and staff costs

 i 30.9

 i 59.4

Long-term debt

 

 i 315.5

 

 i 316.2

Deferred tax liabilities, net

 

 i 602.7

 

 i 729.1

Retirement benefit obligations, net

 i 4.1

 i 4.4

Other non-current liabilities

 

 i 142.6

 

 i 158.8

Total liabilities

 

 i 1,786.5

 

 i 2,037.6

Commitments and contingencies (See Note 14)

REDEEMABLE NONCONTROLLING INTERESTS

 

 i 464.0

 

 i 677.9

EQUITY

Common stock ($ i  i 1.50 /  par,  i  i 480,000,000 /  shares authorized and  i 184,914,488 and  i 186,975,693 shares issued and outstanding as of March 31, 2020, and December 31, 2019, respectively)

 

 i 277.4

 

 i 280.5

Additional paid-in-capital

 i 3,803.7

 i 3,828.5

Treasury shares ( i 3,534,497 and  i 3,545,812 shares held, respectively)

 

( i 137.9)

 

( i 139.5)

Accumulated other comprehensive loss, net of tax

 

( i 511.0)

 

( i 367.1)

Retained earnings

 i 942.8

 i 1,284.1

Total shareholders’ equity

 

 i 4,375.0

 

 i 4,886.5

Nonredeemable noncontrolling interests

 

 i 18.4

 

 i 19.7

Total equity

 

 i 4,393.4

 

 i 4,906.2

Total liabilities, redeemable noncontrolling interests and equity

$

 i 6,643.9

$

 i 7,621.7

The accompanying notes are an integral part of these condensed consolidated financial statements.

1

JANUS HENDERSON GROUP PLC

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)

(U.S. Dollars in Millions, Except per Share Data)

Three months ended

March 31, 

    

2020

    

2019

Revenue:

Management fees

$

 i 439.6

$

 i 441.9

Performance fees

 

 i 14.6

 

( i 5.6)

Shareowner servicing fees

 

 i 50.3

 

 i 35.9

Other revenue

 i 50.4

 i 47.1

Total revenue

 

 i 554.9

 

 i 519.3

Operating expenses:

Employee compensation and benefits

 

 i 155.6

 

 i 145.0

Long-term incentive plans

 

 i 33.6

 

 i 48.4

Distribution expenses

 i 112.2

 i 101.9

Investment administration

 i 11.7

 i 11.8

Marketing

 

 i 6.7

 

 i 7.5

General, administrative and occupancy

 

 i 65.2

 

 i 65.2

Impairment of goodwill and intangible assets

 i 487.3

Depreciation and amortization

 

 i 15.0

 

 i 15.0

Total operating expenses

 

 i 887.3

 

 i 394.8

Operating income (loss)

 

( i 332.4)

 

 i 124.5

Interest expense

 

( i 3.3)

 

( i 4.1)

Investment gains (losses), net

 

( i 50.5)

 

 i 13.3

Other non-operating income (expenses), net

 i 32.2

( i 3.9)

Income (loss) before taxes

 

( i 354.0)

 

 i 129.8

Income tax benefit (provision)

 

 i 68.8

 

( i 29.9)

Net income (loss)

 

( i 285.2)

 

 i 99.9

Net loss (income) attributable to noncontrolling interests

 

 i 38.2

 

( i 5.8)

Net income (loss) attributable to JHG

$

( i 247.0)

$

 i 94.1

Earnings (loss) per share attributable to JHG common shareholders:

Basic

$

( i 1.35)

$

 i 0.48

Diluted

$

( i 1.35)

$

 i 0.48

Other comprehensive income (loss), net of tax:

Foreign currency translation gains (losses)

$

( i 149.1)

$

 i 36.8

Actuarial gains

 

 i 0.1

 

Other comprehensive income (loss), net of tax

 

( i 149.0)

 

 i 36.8

Other comprehensive loss (income) attributable to noncontrolling interests

 

 i 5.1

 

( i 0.1)

Other comprehensive income (loss) attributable to JHG

$

( i 143.9)

$

 i 36.7

Total comprehensive income (loss)

$

( i 434.2)

$

 i 136.7

Total comprehensive loss (income) attributable to noncontrolling interests

 

 i 43.3

 

( i 5.9)

Total comprehensive income (loss) attributable to JHG

$

( i 390.9)

$

 i 130.8

The accompanying notes are an integral part of these condensed consolidated financial statements.

2

JANUS HENDERSON GROUP PLC

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(U.S. Dollars in Millions)

Three months ended

March 31, 

2020

2019

CASH FLOWS PROVIDED BY (USED FOR):

Operating activities:

Net income (loss)

$

( i 285.2)

$

 i 99.9

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

Depreciation and amortization

 i 15.0

 i 15.0

Impairment of goodwill and intangible assets

 i 487.3

Deferred income taxes

( i 110.8)

 i 0.4

Stock-based compensation plan expense

 i 16.6

 i 20.1

Impairment of right-of-use operating asset

 i 4.7

Gain on sale of Geneva

( i 17.4)

Investment (gains) losses, net

 i 50.5

( i 13.3)

Contributions to pension plans in excess of costs recognized

( i 0.1)

( i 1.8)

Contingent consideration adjustment

( i 7.1)

Other, net

( i 13.2)

( i 3.2)

Changes in operating assets and liabilities:

OEIC and unit trust receivables and payables

 i 8.3

 i 11.1

Other assets

 i 57.4

 i 1.8

Other accruals and liabilities

( i 163.4)

( i 169.4)

Net operating activities

 i 37.9

( i 34.7)

Investing activities:

Proceeds from (purchase of):

Investment securities, net

 i 98.3

 i 19.3

Property, equipment and software

( i 8.2)

( i 7.5)

Investment securities by consolidated seeded investment products, net

( i 105.3)

 i 46.1

Cash received (paid) on settled hedges, net

 i 17.9

( i 7.4)

Dividends received from equity-method investments

 i 0.5

 i 0.5

Proceeds from sale of Volantis

 i 0.3

Proceeds from sale of Geneva

 i 38.6

Net investing activities

 i 41.8

 i 51.3

Financing activities:

Purchase of common stock for stock-based compensation plans

( i 39.8)

( i 37.1)

Purchase of common stock for share buyback program

( i 31.2)

( i 30.9)

Dividends paid to shareholders

( i 66.2)

( i 69.7)

Payment of contingent consideration

( i 13.8)

( i 14.1)

Distributions to noncontrolling interests

( i 0.1)

( i 0.1)

Third-party sales (redemptions) in consolidated seeded investment products, net

 i 105.3

( i 46.1)

Principal payments under capital lease obligations

( i 0.2)

( i 0.3)

Net financing activities

( i 46.0)

( i 198.3)

Cash and cash equivalents:

Effect of foreign exchange rate changes

( i 28.0)

 i 5.0

Net change

 i 5.7

( i 176.7)

At beginning of period

 i 796.5

 i 916.6

At end of period

$

 i 802.2

$

 i 739.9

Supplemental cash flow information:

Cash paid for interest

$

 i 7.3

$

 i 7.3

Cash paid for income taxes, net of refunds

$

 i 4.9

$

 i 12.6

Reconciliation of cash and cash equivalents:

Cash and cash equivalents

$

 i 732.5

$

 i 717.1

Cash and cash equivalents held in consolidated VIEs

 i 69.7

 i 22.8

Total cash and cash equivalents

$

 i 802.2

$

 i 739.9

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

JANUS HENDERSON GROUP PLC

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)

(Amounts in Millions)

Accumulated

Additional

other

Nonredeemable

Number of

Common

paid-in

Treasury

comprehensive

Retained

noncontrolling

Total

shares

stock

capital

shares

loss

earnings

interests

equity

Balance at January 1, 2020

 i 187.0

$

 i 280.5

$

 i 3,828.5

$

( i 139.5)

$

( i 367.1)

$

 i 1,284.1

$

 i 19.7

$

 i 4,906.2

Net loss

( i 247.0)

( i 1.2)

( i 248.2)

Other comprehensive income

( i 143.9)

 

 

( i 143.9)

Dividends paid to shareholders

 

( i 66.2)

 

( i 66.2)

Share buyback program

( i 2.1)

( i 3.1)

( i 28.1)

( i 31.2)

Distributions to noncontrolling interests

( i 0.1)

( i 0.1)

Purchase of common stock for stock-based compensation plans

 

 

( i 37.0)

( i 2.8)

 

 

( i 39.8)

Vesting of stock-based compensation plans

( i 4.4)

 i 4.4

 

 

Stock-based compensation plan expense

 

 i 16.6

 

 

 i 16.6

Balance at March 31, 2020

 i 184.9

$

 i 277.4

$

 i 3,803.7

$

( i 137.9)

$

( i 511.0)

$

 i 942.8

$

 i 18.4

$

 i 4,393.4

    

    

    

    

    

Accumulated

    

    

    

Additional

other

Nonredeemable

Number of

Common

paid-in

Treasury

comprehensive

Retained

noncontrolling

Total

shares

stock

capital

shares

loss

earnings

interests

equity

Balance at January 1, 2019

 i 196.4

$

 i 294.6

$

 i 3,824.5

$

( i 170.8)

$

( i 423.5)

$

 i 1,314.5

$

 i 21.5

$

 i 4,860.8

Net income

 i 94.1

 i 1.2

 i 95.3

Other comprehensive loss

 i 36.7

 

 

 i 36.7

Dividends paid to shareholders

 

( i 69.7)

 

( i 69.7)

Share buyback program

( i 1.2)

( i 1.9)

( i 29.0)

( i 30.9)

Distributions to noncontrolling interests

( i 0.1)

( i 0.1)

Purchase of common stock for stock-based compensation plans

 

 

( i 31.4)

( i 5.7)

 

 

( i 37.1)

Vesting of stock-based compensation plans

( i 11.1)

 i 11.1

 

 

Stock-based compensation plan expense

 

 i 20.1

 

 

 i 20.1

Balance at March 31, 2019

 i 195.2

$

 i 292.7

$

 i 3,802.1

$

( i 165.4)

$

( i 386.8)

$

 i 1,309.9

$

 i 22.6

$

 i 4,875.1

The accompanying notes are an integral part of these condensed consolidated financial statements. 

4

JANUS HENDERSON GROUP PLC

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 i 

Note 1 — Basis of Presentation and Significant Accounting Policies

 i 

Basis of Presentation

In the opinion of management of Janus Henderson Group plc (“JHG,” “the Group,” “we,” “us,” “our” and similar terms), the accompanying unaudited condensed consolidated financial statements contain all normal recurring adjustments necessary to fairly state our financial position, results of operations and cash flows in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Such financial statements have been prepared in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. These financial statements should be read in conjunction with the annual consolidated financial statements and notes presented in our Annual Report on Form 10-K for the year ended December 31, 2019. The December 31, 2019, condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. Events subsequent to the balance sheet date have been evaluated for inclusion in the accompanying financial statements through the issuance date.

 i 

Recent Accounting Pronouncements Adopted

Implementation Costs — Cloud Computing Arrangements

In August 2018, the Financial Accounting Standards Board (“FASB”) issued an accounting standards update (“ASU”) that aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement with the requirements for implementation costs incurred to develop or obtain internal-use software. The ASU is effective January 1, 2020, for calendar year-end companies and for the interim periods within those years. The ASU allows either a retrospective or prospective approach to all implementation costs incurred after adoption. We adopted the ASU effective January 1, 2020, using the prospective approach. There were no capitalized implementation costs incurred during the period ended March 31, 2020. We generally expect increased capitalized costs as our previous policy dictated that implementation costs incurred in a hosting arrangement be expensed as incurred.

 i 

Recent Accounting Pronouncements Not Yet Adopted

Retirement Benefit Plans

In August 2018, the FASB issued an ASU that modifies the disclosure requirements for employers that sponsor defined benefit pension plans. The ASU removes, adds and clarifies a number of disclosure requirements related to sponsored benefit plans. The standard is effective January 1, 2021, for calendar year-end companies, and early adoption is permitted. We are evaluating the effect of adopting this new accounting standard.

 / 

 i 

Note 2 — Dispositions

On December 3, 2019, Henderson Global Investors (North America), Inc. (“HGINA”), a subsidiary, of the Group, entered into an agreement to sell its  i 100% ownership interest in Geneva Capital Management LLC (“Geneva”) to GCM Purchaser, LLC. The sale closed on March 17, 2020.

Consideration included aggregate cash consideration of $ i 38.6 million and contingent consideration (the “Earnout”) based on future revenue. Payments under the Earnout are to be made quarterly over a five-year term, with minimum aggregate payments of $ i 20.5 million and maximum aggregate payments of $ i 35.0 million. We recognized a gain on the sale of Geneva of $ i 17.4 million in other non-operating income (expenses), net on the Condensed Consolidated Statements of Comprehensive Income during the three months ended March 31, 2020.

 / 

5

The gain on the sale of Geneva was calculated as follows (in millions):

 i 

Consideration received:

Cash

$

 i 38.6

Minimum earnout

 

 i 20.5

Less carrying amount of assets and liabilities:

Intangible assets

 i 17.9

Other assets

 

 i 0.3

Less: Goodwill allocation

 i 23.5

Net gain on sale, before taxes

$

 i 17.4

 / 

 i 

Note 3 — Consolidation

Variable Interest Entities

Consolidated Variable Interest Entities

Our consolidated variable interest entities (“VIEs”) as of March 31, 2020, and December 31, 2019, include certain consolidated seeded investment products in which we have an investment and act as the investment manager. The assets of these VIEs are not available to us or our creditors. We may not, under any circumstances, access cash and cash equivalents held by consolidated VIEs to use in our operating activities or otherwise. In addition, the investors in these VIEs have no recourse to the credit of JHG.

Unconsolidated Variable Interest Entities

At March 31, 2020, and December 31, 2019, the carrying value of investment securities included on our Condensed Consolidated Balance Sheets pertaining to unconsolidated VIEs was $ i 8.1 million and $ i 9.9 million, respectively. Our total exposure to unconsolidated VIEs represents the value of our economic ownership interest in the investment securities.

Voting Rights Entities

Consolidated Voting Rights Entities

 i 

The following table presents the balances related to consolidated voting rights entities (“VREs”) that were recorded on our Condensed Consolidated Balance Sheets, including our net interest in these products (in millions):

    

March 31, 

    

December 31, 

2020

2019

Investment securities

$

 i 52.7

$

 i 29.9

Cash and cash equivalents

 i 5.7

 

 i 1.5

Other current assets

 i 14.4

 i 0.2

Accounts payable and accrued liabilities

( i 8.6)

( i 0.7)

Total

 i 64.2

 

 i 30.9

Redeemable noncontrolling interests in consolidated VREs

( i 43.2)

 

( i 6.3)

JHG's net interest in consolidated VREs

$

 i 21.0

$

 i 24.6

 / 

Our total exposure to consolidated VREs represents the value of our economic ownership interest in these seeded investment products.

 / 

6

Unconsolidated Voting Rights Entities

At March 31, 2020, and December 31, 2019, the carrying value of investment securities included on our Condensed Consolidated Balance Sheets pertaining to unconsolidated VREs was $ i 30.1 million and $ i 21.5 million, respectively. Our total exposure to unconsolidated VREs represents the value of our economic ownership interest in the investment securities.

 i 

Note 4 — Investment Securities

 i 

Our investment securities as of March 31, 2020, and December 31, 2019, are summarized as follows (in millions):

March 31, 

December 31, 

    

2020

    

2019

Seeded investment products:

Consolidated VIEs

$

 i 548.8

$

 i 924.8

Consolidated VREs

 i 52.7

 i 29.9

Unconsolidated VIEs and VREs

 i 38.2

 i 31.4

Separate accounts

 i 54.8

 i 60.8

Pooled investment funds

 i 0.1

 i 0.1

Total seeded investment products

 

 i 694.6

 

 i 1,047.0

Investments related to deferred compensation plans

 

 i 99.5

 

 i 125.9

Other investments

 i 5.3

 i 5.4

Total investment securities

$

 i 799.4

$

 i 1,178.3

 / 

 i 

Trading Securities

Net unrealized gains (losses) on investment securities held as of the three months ended March 31, 2020 and 2019, are summarized as follows (in millions):

Three months ended

March 31, 

    

2020

    

2019

Unrealized gains (losses) on investment securities held at period end

 

$

( i 39.5)

 

$

 i 11.1

 / 

Derivative Instruments

We maintain an economic hedge program that uses derivative instruments to mitigate against market volatility of certain seeded investments by using index and commodity futures (“futures”), index swaps, total return swaps (“TRSs”) and credit default swaps. Foreign currency exposures associated with our seeded investment products are also hedged by using foreign currency forward contracts. We also have a net investment hedge related to foreign currency translation on hedged seed investments denominated in currencies other than our functional currency.

 i 

We were party to the following derivative instruments as of March 31, 2020, and December 31, 2019 (in millions):

Notional value

    

March 31, 2020

    

December 31, 2019

Futures

$

 i 117.4

$

 i 222.9

Credit default swaps

 i 150.2

 i 143.0

Total return swaps

 i 45.4

 i 46.3

Foreign currency forward contracts

 i 224.8

 i 327.8

 / 
 / 

7

The derivative instruments are not designated as hedges for accounting purposes, with the exception of certain foreign currency forward contracts used for net investment hedging. Changes in fair value of the futures, index swaps, TRSs and credit default swaps are recognized in investment gains (losses), net in our Condensed Consolidated Statements of Comprehensive Income. Changes in the fair value of the foreign currency forward contracts designated as hedges for accounting purposes are recognized in other comprehensive income (loss), net of tax on our Condensed Consolidated Statements of Comprehensive Income.

Derivative assets and liabilities are generally recognized on a gross basis and included in other current assets or accounts payable and accrued liabilities on our Condensed Consolidated Balance Sheets. As of March 31, 2020, derivative assets and liabilities were $ i 13.3 million and $ i 0.2 million, respectively.

 i 

We recognized the following foreign currency translation losses on hedged seed investments denominated in currencies other than our functional currency and gains associated with foreign currency forward contracts under net investment hedge accounting for the three months ended March 31, 2020 and 2019 (in millions):

Three months ended

March 31, 

    

2020

    

2019

Foreign currency translation

    

$

 i 3.0

    

$

 i 0.3

Foreign currency forward contracts

 

( i 3.0)

 

( i 0.3)

Total

$

$

 / 

In addition to using derivative instruments to mitigate against market volatility of certain seeded investments, we also occasionally engage in short sales of securities. As of March 31, 2020, the fair value of securities sold but not yet purchased was $ i 9.6 million. The cash received from the short sale and the obligation to repurchase the shares are classified in other current assets and accounts payable and accrued liabilities on our Condensed Consolidated Balance Sheets, respectively. Fair value adjustments are recognized in investment gains (losses), net on our Condensed Consolidated Statements of Comprehensive Income.

Derivative Instruments in Consolidated Seeded Investment Products

 i 

Certain of our consolidated seeded investment products utilize derivative instruments to contribute to the achievement of defined investment objectives. These derivative instruments are classified within other current assets or accounts payable and accrued liabilities on our Condensed Consolidated Balance Sheets. Gains and losses on these derivative instruments are classified within investment gains (losses), net in our Condensed Consolidated Statements of Comprehensive Income.

Our consolidated seeded investment products were party to the following derivative instruments as of March 31, 2020, and December 31, 2019 (in millions):

Notional Value

    

March 31, 2020

    

December 31, 2019

Futures

$

 i 137.6

$

 i 88.3

Contracts for differences

 i 12.8

 i 15.5

Credit default swaps

 i 20.1

 i 0.1

Total return swaps

 i 0.1

 i 0.1

Interest rate swaps

 

 i 18.7

 

 i 19.4

Options

 

 

 i 1.0

Foreign currency forward contracts

 

 i 441.2

 

 i 167.5

 / 

8

As of March 31, 2020, certain consolidated seeded investment products sold credit protection through the use of credit default swap contracts. The contracts provide alternative credit risk exposure to individual companies and countries outside of traditional bond markets. The terms of the credit default swap contracts range from one to  i five years.

As sellers in credit default swap contracts, the consolidated seeded investment products would be required to pay the notional value of a referenced debt obligation to the counterparty in the event of a default on the debt obligation by the issuer. The notional value represents the estimated maximum potential undiscounted amount of future payments required upon the occurrence of a credit default event. As of March 31, 2020, and December 31, 2019, the notional values of the agreements totaled $ i 1.7 million and $ i 2.2 million, respectively. The credit default swap contracts include recourse provisions that allow for recovery of a certain percentage of amounts paid upon the occurrence of a credit default event. As of March 31, 2020, and December 31, 2019, the fair value of the credit default swap contracts selling protection was  i nil.

Investment Gains (Losses), Net

 i 

Investment gains (losses), net on our Condensed Consolidated Statements of Comprehensive Income included the following for the three months ended March 31, 2020 and 2019 (in millions):

Three months ended

March 31, 

    

2020

    

2019

Seeded investment products and derivatives, net

$

( i 43.5)

$

 i 8.2

Other

 

( i 7.0)

 

 i 5.1

Investment gains (losses), net

$

( i 50.5)

$

 i 13.3

 / 

Cash Flows

 i 

Cash flows related to investment securities for the three months ended March 31, 2020 and 2019, are summarized as follows (in millions):

Three months ended March 31, 

2020

2019

    

    

Sales,

    

    

Sales,

Purchases

settlements

Purchases

settlements

and

and

and

and

settlements

maturities

settlements

maturities

Investment securities by consolidated seeded investment products

$

 i 2.9

$

( i 108.2)

$

( i 176.7)

$

 i 222.8

Investment securities

( i 15.1)

 i 113.4

( i 42.8)

 i 62.1

 / 

9

 i 

Note 5 — Fair Value Measurements

 i 

The following table presents assets and liabilities presented in the financial statements or disclosed in the notes to the financial statements at fair value on a recurring basis as of March 31, 2020 (in millions):

Fair value measurements using:

Quoted prices in

    

active markets for

    

    

    

identical assets

Significant other

Significant

and liabilities

observable inputs

unobservable inputs

(Level 1)

(Level 2)

(Level 3)

Total

Assets:

Cash equivalents

$

 i 384.7

$

$

$

 i 384.7

Investment securities:

 

Consolidated VIEs

 i 191.6

 i 349.6

 i 7.6

 i 548.8

Other investment securities

 i 194.5

 i 56.1

 i 250.6

Total investment securities

 i 386.1

 i 405.7

 i 7.6

 i 799.4

Seed hedge derivatives

 

 i 13.3

 

 i 13.3

Volantis contingent consideration

 

 

 

 i 2.7

 

 i 2.7

Geneva contingent consideration

 i 20.5

 i 20.5

Total assets

$

 i 770.8

$

 i 419.0

$

 i 30.8

$

 i 1,220.6

Liabilities:

Derivatives in consolidated seeded investment products

$

$

 i 17.7

$

$

 i 17.7

Securities sold, not yet purchased

 i 9.6

 i 9.6

Seed hedge derivatives

 i 0.2

 i 0.2

Long-term debt(1)

 i 305.9

 i 305.9

Deferred bonuses

 i 74.3

 i 74.3

Total liabilities

$

 i 9.6

$

 i 323.8

$

 i 74.3

$

 i 407.7

(1)Carried at amortized cost and disclosed at fair value.

 / 
 / 

10

The following table presents assets and liabilities presented in the financial statements or disclosed in the notes to the financial statements at fair value on a recurring basis as of December 31, 2019 (in millions):

Fair value measurements using:

Quoted prices in

    

active markets for

    

    

    

identical assets

Significant other

Significant

and liabilities

observable inputs

unobservable inputs

(Level 1)

(Level 2)

(Level 3)

Total

Assets:

Cash equivalents

$

 i 198.4

$

$

$

 i 198.4

Investment securities:

Consolidated VIEs

 i 573.9

 i 341.0

 i 9.9

 i 924.8

Other investment securities

 i 197.0

 i 56.5

 i 253.5

Total investment securities

 

 i 770.9

 

 i 397.5

 

 i 9.9

 

 i 1,178.3

Seed hedge derivatives

 

 i 0.7

 

 i 0.7

Derivatives in consolidated seeded investment products

Contingent consideration

 

 

 i 2.9

 

 i 2.9

Total assets

$

 i 969.3

$

 i 398.2

$

 i 12.8

$

 i 1,380.3

Liabilities:

Derivatives in consolidated seeded investment products

$

$

 i 0.9

$

$

 i 0.9

Securities sold, not yet purchased

 i 26.5

 i 26.5

Seed hedge derivatives

 i 8.7

 i 8.7

Long-term debt(1)

 i 330.0

 i 330.0

Deferred bonuses

 i 76.6

 i 76.6

Contingent consideration

 i 21.2

 i 21.2

Total liabilities

$

 i 26.5

$

 i 339.6

$

 i 97.8

$

 i 463.9

(1)

Carried at amortized cost and disclosed at fair value.

Level 1 Fair Value Measurements

Our Level 1 fair value measurements consist mostly of seeded investment products, investments in advised mutual funds, cash equivalents and investments related to deferred compensation plans with quoted market prices in active markets. The fair value level of consolidated seeded investment products is determined by the underlying securities of the product. The fair value level of unconsolidated seeded investment products is determined by the underlying inputs used in the calculation of the net asset value (“NAV”) and the trading activity of each product.

Level 2 Fair Value Measurements

Our Level 2 fair value measurements consist mostly of consolidated seeded investment products, derivative instruments and our long-term debt. The fair value of consolidated seeded investment products is determined by the underlying securities of the product. The fair value of our long-term debt is determined using broker quotes and recent trading activity, which are considered Level 2 inputs.

11

Level 3 Fair Value Measurements

Investment Securities

As of March 31, 2020, and December 31, 2019, certain securities within consolidated VIEs were valued using significant unobservable inputs, resulting in Level 3 classification.

 i 

Valuation techniques and significant unobservable inputs used in the valuation of our material Level 3 assets included within consolidated VIEs as of March 31, 2020, and December 31, 2019, were as follows (in millions):

    

    

    

Significant

    

Fair

Valuation

unobservable

As of March 31, 2020

value

technique

inputs

Inputs

Investment securities of consolidated VIEs

$

 i 7.4

 

Discounted

 

Discount rate

 

 i 15%

 

cash flow

 

EBITDA multiple

 

 i 4.73

 

Price-earnings ratio

 

 i 8.86

    

 

  

    

  

    

Significant

    

Fair

 

Valuation

 

unobservable

 

As of December 31, 2019

value

 

technique

 

inputs

 

Inputs

Investment securities of consolidated VIEs

$

 i 9.9

 

Discounted

 

Discount rate

 

 i 15%

 

cash flow

 

EBITDA multiple

 

 i 5.92

 

Price-earnings ratio

 

 i 11.09

 / 
 i 

Sale of Geneva

In the fourth quarter 2019, we entered into an agreement to sell our Milwaukee-based U.S. equities subsidiary, Geneva. The sale closed on March 17, 2020, and the previous contingent consideration liability from the purchase of Geneva was waived as part of the sale agreement. As of March 31, 2020, the value of the contingent consideration liability was  i nil. Consideration included aggregate cash consideration of $ i 38.6 million and contingent consideration (the “Earnout”) based on future revenue. Payments under the Earnout are to be made quarterly over a  i five-year term, with minimum aggregate payments of $ i 20.5 million and maximum aggregate payments of $ i 35.0 million. For further information regarding the contingent consideration asset see Note 2 — Dispositions.

Acquisition of Kapstream

The purchase of Kapstream Capital Pty Limited (“Kapstream”) was a step acquisition and the purchase of the second step ( i 49%) had contingent consideration of up to $ i 43.0 million. Payment of the contingent consideration was subject to all Kapstream products and certain products advised by us, reaching defined revenue targets on the first, second and third anniversaries of January 31, 2017. The contingent consideration was payable in  i three equal installments on the anniversary dates and was indexed to the performance of the premier share class of the Kapstream Absolute Return Income Fund. If Kapstream achieved the defined revenue targets, the holders would receive the value of the contingent consideration adjusted for gains or losses attributable to the mutual fund to which the contingent consideration was indexed, subject to tax withholding. On January 31, 2018, 2019 and 2020, the first, second and third anniversary of the acquisition, Kapstream reached defined revenue targets, and we paid $ i 15.3 million in February 2018, $ i 14.1 million in February 2019 and $ i 13.8 million in February 2020. The February 2020 payment represented the final payment and there was no liability as of March 31, 2020.

Disposal of Volantis

On April 1, 2017, we completed the sale of the Volantis UK Small Cap (“Volantis”) alternative team assets. Consideration for the sale was a  i 10% share of the management and performance fees generated by Volantis for a period of  i three years.

12

The fair value of the Volantis contingent consideration is estimated at each reporting date by forecasting revenues over the contingency period of  i three years. Significant unobservable inputs used in the valuation are limited to forecasted revenues, which factor in expected growth in assets under management (“AUM”) based on performance and industry trends. Increases in forecasted revenue increase the fair value of the consideration, while decreases in forecasted revenue decrease the fair value. The forecasted share of revenues is then discounted back to the valuation date using a discount rate.

As of March 31, 2020, and December 31, 2019, the fair value of the Volantis contingent consideration was $ i 2.7 million and $ i 2.9 million, respectively.

Deferred Bonuses

Deferred bonuses represent liabilities to employees over the vesting period that will be settled by investments in our products. The significant unobservable inputs used to value the liabilities are investment designations and vesting periods.

Changes in Fair Value

 i 

Changes in fair value of our Level 3 assets for the three months ended March 31, 2020 and 2019, were as follows (in millions):

Three months ended

March 31, 

    

2020

    

2019

Beginning of period fair value

$

 i 12.8

$

 i 23.1

Geneva contingent consideration

 i 20.5

Settlements

 

 

( i 0.3)

Movement recognized in net income

 

( i 2.2)

 

( i 3.1)

Movements recognized in other comprehensive income

 

( i 0.3)

 

 i 0.1

End of period fair value

$

 i 30.8

$

 i 19.8

 / 
 i 

Changes in fair value of our individual Level 3 liabilities for the three months ended March 31, 2020 and 2019, were as follows (in millions):

Three months ended March 31, 

2020

2019

    

Contingent

Deferred

Contingent

Deferred

consideration

bonuses

consideration

bonuses

Beginning of period fair value

$

 i 21.2

$

 i 76.6

$

 i 61.3

$

 i 68.5

Fair value adjustments

 

( i 7.1)

 

( i 4.9)

 

 

 i 2.6

Vesting of deferred bonuses

( i 2.3)

( i 3.4)

Amortization of deferred bonuses

 

 

 i 9.8

 

 

 i 13.9

Unrealized gains (losses)

 

 i 0.3

 

 

 i 2.4

 

Distributions

 

( i 13.8)

 

 

( i 14.1)

 

Foreign currency translation

 

( i 0.6)

 

( i 4.9)

 

 i 0.2

 

 i 1.5

End of period fair value

$

$

 i 74.3

$

 i 49.8

$

 i 83.1

 / 

Nonrecurring Fair Value Measurements

Nonrecurring Level 3 fair value measurements include goodwill and intangible assets. We measure the fair value of goodwill and intangible assets on initial recognition using discounted cash flow analysis that requires assumptions

13

regarding projected future earnings and discount rates. Because of the significance of the unobservable inputs in the fair value measurements of these assets, such measurements are classified as Level 3.

 i 

Note 6 — Goodwill and Intangible Assets

 i 

The following tables present movements in our intangible assets and goodwill during the three months ended March 31, 2020 and 2019 (in millions):

    

December 31, 

    

    

Foreign 
currency

    

March 31, 

2019

Amortization

Disposal

Impairment

translation

2020

Indefinite-lived intangible assets:

Investment management agreements

$

 i 2,490.3

$

$

$

( i 263.5)

$

( i 45.2)

$

 i 2,181.6

Trademarks

 

 i 380.8

 

( i 7.7)

( i 0.5)

 

 i 372.6

Definite-lived intangible assets:

Client relationships

 

 i 364.7

 

( i 79.3)

( i 92.6)

( i 6.8)

 

 i 186.0

Accumulated amortization

 

( i 147.2)

 

( i 6.4)

 i 61.4

 i 3.7

 

( i 88.5)

Net intangible assets

$

 i 3,088.6

$

( i 6.4)

$

( i 17.9)

$

( i 363.8)

$

( i 48.8)

$

 i 2,651.7

Goodwill

$

 i 1,504.3

$

$

( i 23.5)

$

( i 123.5)

$

( i 50.2)

$

 i 1,307.1

    

December 31, 

    

    

Foreign 
currency

 

March 31, 

2018

Amortization

Disposal

Impairment

translation

2019

Indefinite-lived intangible assets:

Investment management agreements

$

 i 2,495.5

$

$

$

$

 i 9.2

$

 i 2,504.7

Trademarks

 

 i 380.8

 

 

 i 380.8

Definite-lived intangible assets:

Client relationships

 

 i 363.3

 

 i 1.2

 

 i 364.5

Accumulated amortization

 

( i 116.3)

 

( i 7.4)

( i 0.9)

 

( i 124.6)

Net intangible assets

$

 i 3,123.3

$

( i 7.4)

$

$

$

 i 9.5

$

 i 3,125.4

Goodwill

$

 i 1,478.0

$

$

$

$

 i 15.6

$

 i 1,493.6

 / 

Sale of Geneva

On December 3, 2019, HGINA, a subsidiary of JHG, entered into an agreement to sell its  i 100% ownership interest in Geneva to GCM Purchaser, LLC. The sale closed on March 17, 2020. The transaction included $ i 17.9 million of net intangible assets and goodwill of $ i 23.5 million, as disclosed in the disposal column above. Refer to Note 2 — Disposals for additional information on the sale of Geneva.

Goodwill and intangible asset impairments

In March 2020, the World Health Organization declared the novel coronavirus (“COVID-19”) a pandemic. The impact of COVID-19 on the global economy and businesses is extreme and evolving rapidly, and its future effects are uncertain. Our financial results are directly impacted by the volatility and decline in the global financial markets. In March 2020, the global financial markets declined substantially and our AUM was significantly impacted. We therefore determined that the sudden and severe decline in our AUM was a triggering event for performing an interim impairment assessment of our goodwill and intangible assets.

A discounted cash flow (“DCF”) model was used to determine the estimated fair value of certain investment management agreements and client relationships while a relief from royalty method was used for trademarks. Some of the inputs used in the DCF and relief from royalty models required significant management judgment, including the discount rate, terminal growth rate, forecasted financial results and market returns. Management’s judgment used in the

 / 

14

assessments is more significant under the current market conditions and economic uncertainty created by COVID-19. The carrying value of certain investment management agreements, trademarks and client relationships exceeded their estimated fair value and we recognized impairments of $ i 263.5 million, $ i 7.7 million and $ i 92.6 million, respectively.

A DCF model was also used to estimate the fair value of our sole reporting unit. Goodwill was assessed for impairment by comparing the estimated fair value of our reporting unit to its carrying value. The carrying value of our reporting unit was reduced by the intangible asset impairment charges prior to assessing goodwill for impairment. The assessment of goodwill also required significant management judgment as discussed in the preceding paragraph. The goodwill impairment assessment indicated the carrying value of our reporting unit exceeded its estimated fair value by $ i 123.5 million.

The results of the interim assessment are included in the table above. The impairment charges were recorded in goodwill and intangible asset impairment charges on the Condensed Consolidated Statements of Comprehensive Income. If our AUM is further impacted by the global economic conditions caused by COVID-19, such as adverse and significant declines in the value of global financial markets, additional impairments of goodwill or intangible assets are possible in future periods.

Future Amortization

 i 

Expected future amortization expense related to client relationships is summarized below (in millions):

Future amortization

    

Amount

2020 (remainder of year)

$

 i 7.1

2021

 i 9.4

2022

 

 i 9.4

2023

 

 i 9.2

2024

 

 i 8.0

Thereafter

 

 i 54.4

Total

$

 i 97.5

 / 

 i 

Note 7 — Debt

 i 

Our debt as of March 31, 2020, and December 31, 2019, consisted of the following (in millions):

March 31, 2020

December 31, 2019

    

Carrying

    

Fair

    

Carrying

    

Fair

value

value

value

value

4.875% Senior Notes due 2025

$

 i 315.5

$

 i 305.9

$

 i 316.2

$

 i 330.0

 / 

4.875% Senior Notes Due 2025

The  i 4.875% Senior Notes due 2025 (“2025 Senior Notes”) have a principal value of $ i 300.0 million, pay interest at  i 4.875% semiannually on February 1 and August 1 of each year, and mature on August 1, 2025. The 2025 Senior Notes include unamortized debt premium, net at March 31, 2020, of $ i 15.5 million, which will be amortized over the remaining life of the notes. The unamortized debt premium is recorded as a liability within long-term debt on our Condensed Consolidated Balance Sheets. We fully and unconditionally guarantee the obligations of Janus Capital Group Inc. (“JCG”) in relation to the 2025 Senior Notes.

Credit Facility

At March 31, 2020, we had a $ i 200 million, unsecured, revolving credit facility (“Credit Facility”). JHG and its subsidiaries may use the Credit Facility for general corporate purposes. The rate of interest for each interest period is the aggregate of the applicable margin, which is based on our long-term credit rating and the London Interbank Offered Rate

 / 

15

(“LIBOR”); the Euro Interbank Offered Rate (“EURIBOR”) in relation to any loan in euro (“EUR”); or in relation to any loan in Australian dollar (“AUD”), the benchmark rate for that currency. We are required to pay a quarterly commitment fee on any unused portion of the Credit Facility, which is also based on our long-term credit rating. Under the Credit Facility, the financing leverage ratio cannot exceed  i 3.00x EBITDA. At March 31, 2020, we were in compliance with all covenants contained in, and there were  i no borrowings under the Credit Facility. The maturity date of the Credit Facility is February 16, 2024.

 i 

Note 8 — Income Taxes

Our effective tax rates for the three months ended March 31, 2020 and 2019, were as follows:

 i 

Three months ended

March 31, 

    

2020

    

2019

Effective tax rate

 i 19.4

%  

 i 23.0

%

 / 

The effective tax rate for the three months ended March 31, 2020, compared to the three months ended March 31, 2019 was impacted by a significant reduction in pre-tax book income, resulting in a pre-tax book loss from impairment of intangible assets and goodwill, used to compute the effective tax rate. Most of the impairment charges were temporary in nature and did not have a direct impact on the effective tax rate. The change in the effective tax rate was primarily due to an increase in provision of income taxes attributable to non-controlling interests, a tax shortfall on non-deductible equity-based compensation and non-deductible goodwill. 

As of March 31, 2020, and December 31, 2019, we had $ i 12.6 million and $ i 14.1 million of unrecognized tax benefits held for uncertain tax positions, respectively. We estimate that the existing liability for uncertain tax positions could decrease by up to $ i 0.5 million within the next 12 months, without giving effect to changes in foreign currency translation.

A reduction in the United Kingdom (“UK”) corporation tax rate was scheduled to decline from  i 19% to  i 17% starting April 1, 2020. In March 2020, the UK government announced the UK tax rate would remain at  i 19%. This UK change will be considered enacted only when the Finance Act 2020 is given Royal Assent, which is likely to occur in the second quarter of 2020 at which point UK deferred tax balances will be adjusted from  i 17% to  i 19%. This adjustment of deferred tax assets and liabilities is expected to result in a net non-cash deferred tax expense in the second quarter of 2020 ranging from $ i 6.0 million to $ i 9.0 million.

The Coronavirus Aid, Relief and Economic Security (“CARES”) Act, was signed into legislation on March 27, 2020 and as such is considered enacted for US GAAP. The Act features significant business tax relief provisions and other measures to assist businesses, including, but not limited to, a  i five-year carryback of federal Net Operating Losses, retroactively correcting qualified improvement property, and a temporary increase of Section 163(j) interest limitations. We analyzed the impact of CARES Act tax relief provisions on our financial statements and determined that it did not have a significant impact on us. However, in accordance with FASB Accounting Standards Codification (“ASC”) ASC Topic 740, Income Taxes, we recognized the income tax effects of the CARES Act in our financial statements for the first quarter of 2020, the reporting period during which the CARES Act was signed into law.

 / 

16

 i 

Note 9 — Noncontrolling Interests

Redeemable Noncontrolling Interests

 i 

Redeemable noncontrolling interests as of March 31, 2020, and December 31, 2019, consisted of the following (in millions):

March 31, 

December 31, 

    

2020

    

2019

Consolidated seeded investment products

$

 i 448.7

$

 i 662.8

Intech:

Appreciation rights

 i 12.0

 i 11.8

Founding member ownership interests

 i 3.3

 i 3.3

Total redeemable noncontrolling interests

$

 i 464.0

$

 i 677.9

 / 

Consolidated Seeded Investment Products

Noncontrolling interests in consolidated seeded investment products are classified as redeemable noncontrolling interests when there is an obligation to repurchase units at the investor’s request.

 i 

Redeemable noncontrolling interests in consolidated seeded investment products may fluctuate from period to period and are impacted by changes in our relative ownership, changes in the amount of third-party investment in seeded products and volatility in the market value of the underlying securities included in the portfolios of seeded products. Redemptions of investments by third parties in any particular seeded product are redeemed from the net assets of such seeded product and cannot be redeemed from the assets of our other seeded products or from our other assets.

The following table presents the movement in redeemable noncontrolling interests in consolidated seeded investment products for the three months ended March 31, 2020 and 2019 (in millions):

Three months ended

March 31, 

    

2020

    

2019

Opening balance

$

 i 662.8

$

 i 121.6

Changes in market value

 

( i 36.9)

 

 i 4.5

Changes in ownership

 

( i 171.6)

 

( i 4.2)

Foreign currency translation

( i 5.6)

 i 0.1

Closing balance

$

 i 448.7

$

 i 122.0

 / 

Intech

Intech ownership interests held by a founding member had an estimated fair value of $ i 3.3 million as of March 31, 2020, representing an approximate  i 1.1% ownership of Intech. This founding member is entitled to retain his remaining Intech interests for the remainder of his life and has the option to require us to purchase his ownership interests in Intech at fair value.

Intech appreciation rights are amortized using a graded vesting method over the respective vesting period. The appreciation rights are exercisable upon termination of employment from Intech to the extent vested. Upon exercise, the appreciation rights are settled in Intech equity.

 / 

17

Nonredeemable Noncontrolling Interests

 i 

Nonredeemable noncontrolling interests as of March 31, 2020, and December 31, 2019, were as follows (in millions):

March 31, 

December 31, 

    

2020

    

2019

Nonredeemable noncontrolling interests in:

Seed capital investments

$

 i 5.3

$

 i 6.7

Intech

 

 i 13.1

 

 i 13.0

Total nonredeemable noncontrolling interests

$

 i 18.4

$

 i 19.7

 / 

 i 

Note 10 — Long-Term Incentive and Employee Compensation

We granted $ i 125.9 million in long-term incentive awards during the three months ended March 31, 2020, which generally vest and will be recognized using a graded vesting method over a three- or  i four-year period.

 / 

 i 

Note 11 — Retirement Benefit Plans

We operate defined contribution retirement benefit plans and defined benefit pension plans.

The main defined benefit pension plan sponsored by us is the defined benefit section of the Janus Henderson Group UK Pension Scheme (“JHGPS”).

Net Periodic Benefit Credit

 i 

The components of net periodic benefit credit in respect of defined benefit plans for the three months ended March 31, 2020 and 2019, include the following (in millions):

Three months ended

March 31, 

    

2020

    

2019

Service cost

$

( i 0.2)

$

( i 0.3)

Interest cost

 

( i 4.3)

 

( i 4.7)

Amortization of prior service cost

( i 0.1)

Expected return on plan assets

 

 i 4.6

 

 i 5.4

Net periodic benefit credit

$

$

 i 0.4

 / 

 / 

 i 

Note 12 — Accumulated Other Comprehensive Loss

 i 

Changes in accumulated other comprehensive loss, net of tax for the three months ended March 31, 2020 and 2019, were as follows (in millions):

Three months ended March 31, 

2020

2019

Foreign

Retirement benefit

Foreign

Retirement
benefit

    

currency

    

asset, net

    

Total

    

currency

    

asset, net

    

Total

Beginning balance

$

( i 386.2)

$

 i 19.1

$

( i 367.1)

$

( i 448.2)

$

 i 24.7

$

( i 423.5)

Other comprehensive income (loss)

( i 149.1)

 i 0.1

( i 149.0)

 i 36.8

 i 36.8

Less: other comprehensive loss (income) attributable to noncontrolling interests

 i 5.1

 i 5.1

( i 0.1)

( i 0.1)

Ending balance

$

( i 530.2)

$

 i 19.2

$

( i 511.0)

$

( i 411.5)

$

 i 24.7

$

( i 386.8)

 / 

 / 

18

 i 

The components of other comprehensive income (loss), net of tax for the three months ended March 31, 2020 and 2019, were as follows (in millions):

Three months ended March 31, 

2020

2019

Pre-tax

Tax

Pre-tax

Tax

    

amount

    

impact

    

Net amount

    

amount

    

impact

    

Net amount

Foreign currency translation adjustments

$

( i 151.3)

$

 i 2.2

$

( i 149.1)

$

 i 35.3

$

 i 1.5

$

 i 36.8

Retirement benefit asset, net

 i 0.1

 i 0.1

Total other comprehensive income (loss)

$

( i 151.2)

$

 i 2.2

$

( i 149.0)

$

 i 35.3

$

 i 1.5

$

 i 36.8

 / 

 i 

19

Note 13 — Earnings (Loss) and Dividends Per Share

Earnings (Loss) Per Share

 i 

The following is a summary of the earnings (loss) per share calculation for the three months ended March 31, 2020 and 2019 (in millions, except per share data):

Three months ended

March 31, 

    

2020

    

2019

Net income (loss) attributable to JHG

$

( i 247.0)

$

 i 94.1

Allocation of earnings to participating stock-based awards

( i 2.4)

Net income (loss) attributable to JHG common shareholders

$

( i 247.0)

$

 i 91.7

Weighted-average common shares outstanding — basic

 

 i 182.4

 

 i 191.8

Dilutive effect of non-participating stock-based awards

 i 0.7

Weighted-average common shares outstanding — diluted

 

 i 182.4

 

 i 192.5

Earnings (loss) per share:

Basic and diluted (two class)

$

( i 1.35)

$

 i 0.48

 / 
 i 

The following instruments are anti-dilutive and have not been included in the weighted-average diluted shares outstanding calculation (in millions):

Three months ended

March 31, 

    

2020

    

2019

Unvested nonparticipating stock awards

 

 i 2.3

 

 i 1.0

 / 

Dividends Per Share

The payment of cash dividends is within the discretion of our Board of Directors and depends on many factors, including, but not limited to, our results of operations, financial condition, capital requirements, legal requirements and general business conditions.

 i 

The following is a summary of cash dividends paid during the three months ended March 31, 2020:

Dividend

Date

Dividends paid

Date

per share

    

declared

(in US$ millions)

    

paid

$

 i 0.36

February 3, 2020

 

$

 i 66.2

March 5, 2020

 / 

On April 29, 2020, our Board of Directors declared a cash dividend of $ i 0.36 per share. The quarterly dividend will be paid on May 27, 2020, to shareholders of record at the close of business on May 11, 2020.

 i 

20

Note 14 — Commitments and Contingencies

Commitments and contingencies may arise in the normal course of business. As of March 31, 2020, there were no material changes in the commitments and contingencies as reported in our Annual Report on Form 10-K for the year ended December 31, 2019.

Litigation and Other Regulatory Matters

We are periodically involved in various legal proceedings and other regulatory matters.

Eisenberg v. Credit Suisse AG and Janus Indices, Halbert v. Credit Suisse AG and Janus Indices, Qiu v. Credit Suisse AG and Janus Indices, and Y-GAR Capital v. Credit Suisse AG and Janus Indices

On March 15, 2018, a class action lawsuit was filed in the United States District Court for the Southern District of New York (“SDNY”) against Janus Index & Calculation Services LLC, which effective January 1, 2019, was renamed Janus Henderson Indices LLC (“Janus Indices”), a subsidiary of JHG, on behalf of a class consisting of investors who purchased VelocityShares Daily Inverse VIX Short-Term ETN (Ticker: XIV) between January 29, 2018, and February 5, 2018 (Eisenberg v. Credit Suisse AG and Janus Indices). Credit Suisse, the issuer of the XIV notes, is also named as a defendant in the lawsuit. The plaintiffs generally allege statements by Credit Suisse and Janus Indices, including those in the registration statement, were materially false and misleading based on its discussion of how the intraday indicative value (“IIV”) is calculated and that the IIV was not an accurate gauge of the economic value of the notes. On April 17, 2018, a second lawsuit was filed against Janus Indices and Credit Suisse in the United States District Court of the Northern District of Alabama by certain investors in XIV (Halbert v. Credit Suisse AG and Janus Indices).

On May 4, 2018, a third lawsuit, styled as a class action on behalf of investors who purchased XIV between January 29, 2018, and February 5, 2018, was filed against Janus Indices and Credit Suisse AG in the SDNY (Qiu v. Credit Suisse AG and Janus Indices). The Halbert and Qiu allegations generally copy the allegations in the Eisenberg case.

On August 20, 2018, an amended complaint was filed in the Eisenberg and Qiu cases (which have been consolidated in the SDNY under the name Set Capital LLC, et al. v. Credit Suisse AG, et al.), adding Janus Distributors LLC, doing business as Janus Henderson Distributors, and Janus Henderson Group plc as parties, and adding allegations of market manipulation by all of the defendants. The Janus Henderson and Credit Suisse defendants moved to dismiss the Set Capital amended complaint, and on September 25, 2019, the court dismissed all claims against all defendants. The court denied the plaintiffs’ request for an opportunity to further amend their complaint, and therefore dismissed the case in its entirety. Plaintiffs have filed an appeal in the U.S. Court of Appeals for the Second Circuit.

The defendants in Halbert — Credit Suisse and Janus Indices — jointly moved to dismiss the amended complaint. On August 22, 2019, the court granted in part and denied in part the defendants’ motion to dismiss the claims. The court dismissed all claims against Janus Indices — including all federal securities claims — other than a claim for negligent misrepresentation. On September 26, 2019, Janus Indices filed its answer to the complaint. As of March 31, 2020, the case remains in the discovery phase.

On February 7, 2019, a fourth lawsuit was filed against Janus Indices, Janus Distributors LLC, Janus Henderson Group plc and Credit Suisse in the United States District Court for the Eastern District of New York (“EDNY”) by certain investors in XIV (Y-GAR Capital LLC v. Credit Suisse Group AG, et al.). The allegations in Y-GAR generally asserted that the disclosures relating to XIV were false and misleading. On March 29, 2019, the plaintiff withdrew the suit from the EDNY and re-filed it in the SDNY. The Janus Henderson and Credit Suisse defendants each moved to dismiss the claims against them. On January 2, 2020, the court dismissed all claims against all defendants. On February 3, 2020, the plaintiff filed a notice of appeal with the U.S. Court of Appeals for the Second Circuit, however, the plaintiff withdrew the appeal on April 14, 2020. Accordingly, the Y-GAR matter has been concluded.

We believe the remaining claims in these exchange-traded note lawsuits are without merit and are vigorously defending the actions. As of March 31, 2020, we cannot reasonably estimate possible losses from the remaining claims in the exchange-traded note lawsuits.

21

With respect to the unaudited financial statements of Janus Henderson Group plc as of and for the three-month period ended March 31, 2020, appearing herein, PricewaterhouseCoopers LLP (United States) reported that they have applied limited procedures in accordance with professional standards for a review of such information. However, their separate report dated April 30, 2020, appearing herein, states that they did not audit and they do not express an opinion on that unaudited financial statements. Accordingly, the degree of reliance on their report on such information should be restricted in light of the limited nature of the review procedures applied. PricewaterhouseCoopers LLP (United States) is not subject to the liability provisions of Section 11 of the Securities Act of 1933 for their report on the unaudited financial statements because that report is not a "report" or a "part" of the registration statement prepared or certified by PricewaterhouseCoopers LLP (United States) within the meaning of Sections 7 and 11 of the Act.

22

Graphic

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Shareholders of Janus Henderson Group plc

Results of Review of Interim Financial Statements

We have reviewed the accompanying condensed consolidated balance sheet of Janus Henderson Group plc and its subsidiaries (the “Company”) as of March 31, 2020, and the related condensed consolidated statements of comprehensive income (loss), of changes in equity, and of cash flows for the three-month periods ended March 31, 2020 and 2019, including the related notes (collectively referred to as the “interim financial statements”). Based on our reviews, we are not aware of any material modifications that should be made to the accompanying interim financial statements for them to be in conformity with accounting principles generally accepted in the United States of America.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of the Company as of December 31, 2019, and the related consolidated statements of comprehensive income, of changes in equity, and of cash flows for the year then ended (not presented herein), and in our report dated February 26, 2020, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2019, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

Basis for Review Results

These interim financial statements are the responsibility of the Company’s management. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our review in accordance with the standards of the PCAOB. A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

/s/ PricewaterhouseCoopers LLP

Denver, Colorado

April 30, 2020

23

Item 2.   MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF JANUS HENDERSON GROUP PLC

FORWARD-LOOKING STATEMENTS

Certain statements in this Quarterly Report on Form 10-Q not based on historical facts are “forward-looking statements” within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995, as amended, Section 21E of the Securities Exchange Act of 1934 (“Exchange Act”), as amended, and Section 27A of the Securities Act of 1933, as amended (“Securities Act”). Such forward-looking statements involve known and unknown risks and uncertainties that are difficult to predict and could cause our actual results, performance or achievements to differ materially from those discussed. These include statements as to our future expectations, beliefs, plans, strategies, objectives, events, conditions, financial performance, prospects, or future events. In some cases, forward-looking statements can be identified by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “likely,” “will,” “would” and similar words and phrases. Forward-looking statements are necessarily based on estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Accordingly, you should not place undue reliance on forward-looking statements, which speak only as of the date they are made, and are not guarantees of future performance. We do not undertake any obligation to publicly update or revise these forward-looking statements.

Various risks, uncertainties, assumptions and factors that could cause our future results to differ materially from those expressed by the forward-looking statements included in this Quarterly Report on Form 10-Q include, but are not limited to, risks, uncertainties, assumptions and factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2019, and this Quarterly Report on Form 10-Q under headings such as “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations of Janus Henderson Group plc” and “Quantitative and Qualitative Disclosures about Market Risk,” and in other filings or furnishings made by the Company with the SEC from time to time.

AVAILABLE INFORMATION

We make available free of charge our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K and amendments thereto as soon as reasonably practicable after such filing has been made with the SEC. These reports may be obtained through our Investor Relations website (http://janushenderson.com/ir) and are available in print at no charge upon request by any shareholder. The contents of our website are not incorporated herein for any purpose. The SEC also maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC at http://www.sec.gov.

Charters for the Audit Committee, Compensation Committee, Risk Committee, and Nominating and Corporate Governance Committee of our Board of Directors, our Corporate Governance Guidelines, our Code of Business Conduct, and our Officer Code of Ethics for the Chief Executive Officer (“CEO”) and Senior Financial Officers (our “Senior Officer Code”) are posted on our Investor Relations website (janushenderson.com\ir) and are available in print at no charge upon request by any shareholder. Within the time period prescribed by SEC and New York Stock Exchange (“NYSE”) regulations, we will post on our website any amendment to our Senior Officer Code and our Code of Business Conduct or any waivers thereof. The information on our website is not incorporated by reference into this report.

Business Overview

We are an independent global asset manager, specializing in active investment across all major asset classes. We actively manage a broad range of investment products for institutional and retail investors across five capabilities: Equities, Fixed Income, Quantitative Equities, Multi-Asset and Alternatives.

On May 30, 2017, JHG completed a merger of equals with JCG (the “Merger”). As a result of the Merger, JCG and its consolidated subsidiaries became subsidiaries of JHG.

24

Segment Considerations

We are a global asset manager and manage a range of investment products, operating across various product lines, distribution channels and geographic regions. However, information is reported to the chief operating decision-maker, the CEO, on an aggregated basis. Strategic and financial management decisions are determined centrally by the CEO and, on this basis, we operate as a single segment investment management business.

Impact of COVID-19

In March 2020, the World Health Organization declared the novel coronavirus (“COVID-19”) a pandemic. COVID-19 is having a significant impact on the global economy primarily through preventative measures taken by businesses and governments to restrict its spread. We are addressing the challenges of COVID-19 by protecting the health and well-being of our employees while continuing to service our clients who rely on us to invest and manage their money. However, COVID-19 is impacting our financial statements, capital and liquidity, and business operations and each of these impacts is discussed below.

Financial Statement Impact

The economic impact of COVID-19 adversely affected our financial results during the first quarter 2020. Our revenues are primarily derived from management fees and performance fees, which are in turn dependent on the value and composition of our AUM, which has been negatively impacted by the significant decline in the global financial markets. COVID-19 has also led to volatility in foreign currency exchange rates, which directly impacts our revenue and expenses as well as the valuation of assets and liabilities denominated in foreign currencies. We have significant AUM and subsidiary balances denominated in Great British pounds (“GBP”), Australian Dollars (“AUD”) and Euros (“EUR”) and the translation of these items to U.S. dollars (“USD”) had financial statement implications during the reporting period.

Further, the decline in AUM and the economic uncertainty of COVID-19 are also affecting the value of our intangible assets and goodwill, which resulted in impairments of $363.8 million and $123.5 million, respectively, during the first quarter of 2020. If our AUM is further impacted by the global economic conditions caused by COVID-19, such as adverse and significant declines in the value of global financial markets, additional impairments of goodwill or intangible assets are possible in future periods. Refer to Note 6 — Goodwill and Intangible Assets for additional information on our intangible asset and goodwill impairment assessment.

Capital and Liquidity Impact

Our financial condition is stable, allowing us to effectively manage the financial impacts of COVID-19. We hold surplus capital and liquidity over our requirements which provides resilience against market downturns. We believe our capital structure should provide us with sufficient resources and flexibility to meet present and future cash needs, including access to an unsecured revolving $200 million credit facility. However, given the uncertainty surrounding the current economic environment, we are tightly controlling all costs and capital expenditures. We currently do not expect to suspend quarterly dividend payments to shareholders or the share buyback program, however, the assessment of these items is ongoing.

Business Operations Impact

COVID-19 is also affecting our business operations, however, we have a robust and detailed business continuity plan in place to ensure that our operations can continue effectively during the COVID-19 pandemic, including processes to limit the spread of the virus between employees. For the health and well-being of our employees, we have modified our business practices in accordance with social distancing guidelines to allow work-from-home arrangements, flexible work schedules, and restrict business-related travel. Our employees are following the guidelines and over 95% are working remotely from their homes. Our technology capabilities have the capacity to support employees’ remote working arrangements. While COVID-19 has created a new and challenging landscape for our business operations, our ability to adequately maintain our operations, internal controls and client relationships has not been adversely affected by these modifications.

25

The extent of the impact of COVID-19 on our business, financial condition and results of operations also depends on future developments, including the duration of the pandemic and the volatility of the global financial markets, all of which are highly uncertain. We continue to assess the risks associated with COVID-19 and to mitigate them where possible.

Revenue

Revenue primarily consists of management fees and performance fees. Management fees are generally based on a percentage of the market value of our AUM and are calculated using either the daily, month-end or quarter-end average asset balance in accordance with contractual agreements. Accordingly, fluctuations in the financial markets have a direct effect on our operating results. Additionally, our AUM may outperform or underperform the financial markets and therefore may fluctuate in varying degrees from that of the general market.

Performance fees are specified in certain fund and client contracts, and are based on investment performance either on an absolute basis or compared to an established index over a specified period of time. This is often subject to a hurdle rate. Performance fees are recognized at the end of the contractual period (typically monthly, quarterly or annually) if the stated performance criteria are achieved. Certain fund and client contracts allow for negative performance fees where there is underperformance against the relevant index.

FIRST QUARTER 2020 SUMMARY

First Quarter 2020 Highlights

Solid long-term investment performance, with 65% and 66% of our AUM outperforming relevant benchmarks on a three- and five-year basis, respectively, as of March 31, 2020.

AUM decreased to $294.4 billion, down (21%), from the year ended December 31, 2019, due to adverse markets, net outflows and unfavorable foreign currency translation.

Interim impairment assessment resulted in goodwill and intangible asset impairment charges of $487.3 million.

First quarter 2020 diluted earnings (loss) per share was $(1.35), or $0.60, on an adjusted basis. Refer to the Non-GAAP Financial Measures section for information on adjusted non-GAAP figures.

On February 3, 2020, the Board declared a $0.36 per share dividend for the first quarter 2020.

During the first quarter 2020, we acquired 2,061,205 shares of our common stock for $31.2 million.

Financial Summary

Results are reported on a U.S. GAAP basis. Adjusted non-GAAP figures are presented in the Non-GAAP Financial Measures section.

Revenue for the first quarter 2020 was $554.9 million, an increase of $35.6 million, or 7%, from the first quarter 2019, primarily driven by increases of $20.2 million in performance fees and $14.4 million in shareowner servicing fees.

Total operating expenses for the first quarter 2020 were $887.3 million, an increase of $492.5 million, or 125%, compared to operating expenses in the first quarter 2019, primarily driven by a $487.3 million impairment of our goodwill, and certain mutual fund investment management agreements and client relationships. Also contributing to the increase in operating expenses were increases of $10.3 million in distribution expenses and $10.6 million in employee compensation and benefits, partially offset by a decrease of $14.8 million in long-term incentive plan expenses.

Our operating loss for the first quarter 2020 was $(332.4) million, a decrease of $456.9 million, or (367%), compared to the first quarter 2019. Our operating margin was (59.9%) in the first quarter 2020 compared to 24.0% in the first quarter 2019.

26

Net income (loss) attributable to JHG in the first quarter 2020 was $(247.0) million, a decrease of $341.1 million, or (362%), compared to the first quarter 2019 partly due to the factors impacting revenue and operating expense discussed above. In addition, net loss (income) attributable to noncontrolling interests increased $44.0 million and other non-operating income (expenses), net improved $36.1 million due to a $17.4 million gain and a $7.1 million contingent consideration adjustment related to the sale of Geneva, as well as favorable foreign currency translation during the first quarter 2020. These increases were partially offset by a decline of $63.8 million in investment gains (losses), net from the first quarter 2019, primarily driven by fair value adjustments in relation to our seeded investment products and derivative instruments.

Our ordinary dividend in respect of the first quarter 2020 totaled $0.36 per share.

Investment Performance of Assets Under Management

The following table is a summary of investment performance as of March 31, 2020:

Percentage of AUM outperforming benchmark

    

1 year

    

3 years

    

5 years

 

Equities

 

43

%  

69

%  

70

%

Fixed Income

 

48

%  

55

%  

61

%

Multi-Asset

 

86

%  

87

%  

93

%

Quantitative Equities

 

35

%  

28

%  

9

%

Alternatives

 

95

%  

97

%  

97

%

Total Group

 

50

%  

65

%  

66

%

Assets Under Management

Our AUM as of March 31, 2020, was $294.4 billion, a decrease of $80.4 billion, or (21%), from December 31, 2019, driven primarily by adverse market movements of $56.2 billion, net redemptions of $12.2 billion and unfavorable foreign currency translation of $7.8 billion.

Market volatility in April 2020 has led to an increase in our AUM from March 31, 2020, which will positively impact our results of operations and financial condition. Our AUM as of April 23, 2020 has increased more than 5% since March 31, 2020.

Our non-USD AUM is primarily denominated in GBP, EUR and AUD. During the three months ended March 31, 2020, the USD strengthened against the GBP, the AUD and the EUR, resulting in a $7.8 billion decrease to our AUM. As of March 31, 2020, approximately 32% of our AUM was non-USD denominated, resulting in a net unfavorable currency effect, particularly in products exposed to GBP.

VelocityShares exchange-traded notes (“ETNs”) and certain index products are not included within our AUM as we are not the named adviser or subadviser to ETNs or index products. VelocityShares ETN assets totaled $3.7 billion and $3.1 billion as of March 31, 2020, and December 31, 2019, respectively. VelocityShares index product assets not included within our AUM totaled $3.1 billion and $3.0 billion as of March 31, 2020, and December 31, 2019, respectively.

27

Our AUM and flows by capability for the three months ended March 31, 2020 and 2019, were as follows (in billions):

    

Closing AUM

    

    

    

    

    

    

Closing AUM

December 31,

Net sales

             

March 31, 

2019

Sales

Redemptions(1)

(redemptions)

Markets

FX(2)

Disposals(3)

2020

By capability

 

  

 

  

 

  

  

 

  

 

  

 

  

 

  

Equities

$

204.0

$

8.8

$

(15.7)

$

(6.9)

$

(40.3)

$

(2.9)

$

(4.0)

$

149.9

Fixed Income

 

74.8

 

8.0

 

(11.4)

 

(3.4)

 

(2.1)

 

(4.0)

 

 

65.3

Quantitative Equities

 

45.2

 

0.4

 

(2.4)

 

(2.0)

 

(8.5)

(0.1)

 

 

34.6

Multi-Asset

 

39.8

 

3.5

 

(2.5)

 

1.0

(5.0)

 

(0.3)

 

(0.2)

 

35.3

Alternatives

 

11.0

 

0.7

 

(1.6)

 

(0.9)

 

(0.3)

 

(0.5)

 

 

9.3

Total

$

374.8

$

21.4

$

(33.6)

$

(12.2)

$

(56.2)

$

(7.8)

$

(4.2)

$

294.4

    

Closing AUM

    

    

    

    

    

    

Closing AUM

December 31,

Net sales

March 31, 

    

2018

    

Sales

    

Redemptions(1)

    

(redemptions)

    

Markets

    

FX(2)

    

Disposals(3)

    

2019

By capability

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Equities

$

167.6

$

6.9

$

(9.8)

$

(2.9)

$

23.7

$

0.4

$

$

188.8

Fixed Income

 

72.4

 

4.9

 

(7.7)

 

(2.8)

 

2.2

 

0.7

 

 

72.5

Quantitative Equities

 

44.3

 

0.7

 

(1.7)

 

(1.0)

 

6.3

 

 

 

49.6

Multi-Asset

 

30.2

 

2.2

 

(1.5)

 

0.7

 

2.4

 

0.1

 

 

33.4

Alternatives

 

14.0

 

0.9

 

(2.3)

 

(1.4)

 

0.3

 

0.1

 

 

13.0

Total

$

328.5

$

15.6

$

(23.0)

$

(7.4)

$

34.9

$

1.3

$

$

357.3

(1)Redemptions include the impact of client transfers, which could result in a positive balance on occasion.

(2)FX reflects movements in AUM resulting from changes in foreign currency rates as non-USD denominated AUM is translated into USD.

(3)Disposals relate to the sale of Geneva. Refer to Note 2 — Dispositions for information regarding the sale.

Closing Assets Under Management

The following table presents the closing AUM, split by client type and client location, as of March 31, 2020 (in billions):

    

Closing AUM

By client type

March 31, 2020

Intermediary

$

136.5

Institutional

 

101.8

Self-directed

 

56.1

Total

$

294.4

28

    

Closing AUM

By client location

March 31, 2020

North America

$

161.9

EMEA & LatAm

 

90.0

Asia-Pacific

 

42.5

Total

$

294.4

Valuation of Assets Under Management

The fair value of our AUM is based on the value of the underlying cash and investment securities of our funds, trusts and segregated mandates. A significant proportion of these securities is listed or quoted on a recognized securities exchange or market and is regularly traded thereon; these investments are valued based on unadjusted quoted market prices. Other investments including over the counter derivative contracts (which are dealt in or through a clearing firm, exchanges or financial institutions) will be valued by reference to the most recent official settlement price quoted by the appointed market vendor, and in the event no price is available from this source, a broker quotation may be used. Physical property held is valued monthly by a specialist independent appraiser.

When a readily ascertainable market value does not exist for an investment, the fair value is calculated using a variety of methodologies, including the expected cash flows of its underlying net asset base, taking into account applicable discount rates and other factors; comparable securities or relevant indices; recent financing rounds; revenue multiples; or a combination thereof. Judgment is used to ascertain if a formerly active market has become inactive and to determine fair values when markets have become inactive. Our Fair Value Pricing Committee is responsible for determining or approving these unquoted prices, which are reported to those charged with governance of the funds and trusts. For funds that invest in markets that are closed at their valuation point, an assessment is made daily to determine whether a fair value pricing adjustment is required to the fund’s valuation. This may be due to significant market movements in other correlated open markets, scheduled market closures or unscheduled market closures as a result of natural disaster or government intervention.

Third-party administrators hold a key role in the collection and validation of prices used in the valuation of the securities. Daily price validation is completed using techniques such as day-on-day tolerance movements, invariant prices, excessive movement checks and intra-vendor tolerance checks. Our data management team performs oversight of this process and completes annual due diligence on the processes of third-parties.

In other cases, we and the sub-administrators perform a number of procedures to validate the pricing received from third-party providers. For actively traded equity and fixed income securities, prices are received daily from both a primary and secondary vendor. Prices from the primary and secondary vendors are compared to identify any discrepancies. In the event of a discrepancy, a price challenge may be issued to both vendors. Securities with significant day-to-day price changes require additional research, which may include a review of all news pertaining to the issue and issuer, and any corporate actions. All fixed income prices are reviewed by our fixed income trading desk to incorporate market activity information available to our traders. In the event the traders have received price indications from market makers for a particular issue, this information is transmitted to the pricing vendors.

We leverage the expertise of our fund management teams across the business to cross-invest assets and create value for our clients. Where cross investment occurs, assets and flows are identified and the duplication is removed.

Results of Operations

Foreign Currency Translation

Foreign currency translation impacts our Results of Operations. The translation of GBP to USD is the primary driver of foreign currency translation in expenses. The GBP weakened against the USD during the three months ended March 31, 2020, compared to the three months ended March 31, 2019. Meaningful impacts to our operating expenses are discussed in the Operating Expenses section below. Revenue is also impacted by foreign currency translation, but the impact is generally determined by the primary currency of the individual funds.

29

Revenue

Three months ended

March 31, 

    

2020

    

2019

Revenue (in millions):

 

  

 

  

Management fees

$

439.6

$

441.9

Performance fees

 

14.6

 

(5.6)

Shareowner servicing fees

 

50.3

 

35.9

Other revenue

 

50.4

 

47.1

Total revenue

$

554.9

$

519.3

Management fees

Management fees decreased by $2.3 million during the three months ended March 31, 2020, compared to the three months ended March 31, 2019 primarily due to lower management fee margins of $19.3 million, which was partially offset by a quarter-over-quarter increase in average AUM of $15.2 million.

Performance fees

Performance fees are derived across a number of product ranges. Pooled fund and segregated mandate performance fees are recognized on a quarterly or annual basis, while mutual fund performance fees are recognized on a monthly basis. Performance fees by product type consisted of the following for the three months ended March 31, 2020 and 2019 (in millions):

Three months ended

March 31, 

    

2020

    

2019

Performance fees (in millions):

 

  

 

  

SICAVs

$

0.2

$

UK OEICs and unit trusts

 

1.3

 

Offshore absolute return

 

4.0

 

Segregated mandates

 

11.0

 

3.3

Mutual funds

 

(1.9)

 

(8.9)

Total performance fees

$

14.6

$

(5.6)

For the three months ended March 31, 2020, performance fees improved $20.2 million compared to the three months ended March 31, 2019, primarily due to performance fee increases of $7.7 million on segregated mandates due to higher performance fee crystallizations, $7.0 million in mutual fund performance in relation to the benchmarks and $4.0 million in offshore absolute return hedge funds.

Shareowner servicing fees

Shareowner servicing fees are primarily composed of U.S. mutual fund servicing fees. For the three months ended March 31, 2020, shareowner servicing fees increased $14.4 million compared to the three months ended March 31, 2019, primarily due to an $11.3 million increase in relation to correcting the presentation of certain servicing fees and expenses. The presentation for the three months ended March 31, 2020, reflects these fees on a gross basis in shareowner servicing fees on the Condensed Consolidated Statements of Comprehensive Income, while the fees were netted in distribution expenses in the three months ended March 31, 2019. The correction is offset in distribution expenses on the Condensed Consolidated Statements of Comprehensive Income. Transfer agent servicing fees of $2.8 million also contributed to the increase during the three months ended March 31, 2020.

30

Other revenue

Other revenue is primarily composed of Velocity Shares ETN fees, 12b-1 distribution fees, general administration charges and other fee revenue. Other revenue increased by $3.3 million during the three months ended March 31, 2020, compared to the three months ended March 31, 2019, primarily due to increases of $2.2 million in distribution and other fee revenue and $1.4 million in 12b-1 fees.

Operating Expenses

Three months ended

March 31, 

    

2020

    

2019

Operating expenses (in millions):

 

  

 

  

Employee compensation and benefits

$

155.6

$

145.0

Long-term incentive plans

 

33.6

 

48.4

Distribution expenses

 

112.2

 

101.9

Investment administration

 

11.7

 

11.8

Marketing

 

6.7

 

7.5

General, administrative and occupancy

 

65.2

 

65.2

Impairment of goodwill and intangible assets

487.3

Depreciation and amortization

 

15.0

 

15.0

Total operating expenses

$

887.3

$

394.8

Employee compensation and benefits

Employee compensation and benefits increased by $10.6 million during the three months ended March 31, 2020, compared to the three months ended March 31, 2019, primarily driven by increases of $9.2 million in variable compensation due to higher operating profit, $2.4 million in temporary staffing charges and project costs, and $1.6 million in annual base-pay increases during the three months ended March 31, 2020. These increases were partially offset by favorable foreign currency translation of $1.6 million.

Long-term incentive plans

Long-term incentive plans decreased by $14.8 million during the three months ended March 31, 2020, compared to the three months ended March 31, 2019, primarily driven by $15.8 million in fair value adjustments related to mutual fund share awards during the three months ended March 31, 2020.

Distribution expenses

Distribution expenses are paid to financial intermediaries for the distribution of our retail investment products and are typically calculated based on the amount of the intermediary-sourced AUM. Distribution expenses increased $10.3 million during the three months ended March 31, 2020, compared to the three months ended March 31, 2019. The increase was primarily due to $11.3 million in relation to correcting the presentation of certain services fees and expenses as discussed above in shareowner servicing fees and $3.6 million due to an increase in average AUM. These increases were partially offset by a decrease of $6.5 million in lower management fee margins.

31

Marketing

Marketing expenses decreased by $0.8 million during the three months ended March 31, 2020, compared to the three months ended March 31, 2019. The decrease was primarily driven by lower marketing material and advertising costs during the three months ended March 31, 2020.

General, administrative and occupancy

General, administrative and occupancy expenses remained flat during the three months ended March 31, 2020, compared to the three months ended March 31, 2019. The significant items impacting these periods include a $4.7 million impairment of sub-leased office space recognized during the three months ended March 31, 2019, which is partially offset by increases of $2.4 million in legal and professional consultancy fees and $2.1 million in information technology costs during the three months ended March 31, 2020.

Impairment of goodwill and intangible assets

Goodwill and intangible asset impairment charges increased by $487.3 million during the three months ended March 31, 2020, compared to the three months ended March 31, 2019, due to impairment of our goodwill and certain mutual fund investment management agreements and client relationships.

Non-Operating Income and Expenses

Three months ended

March 31, 

    

2020

    

2019

Non-operating income and expenses (in millions):

 

  

 

  

Interest expense

$

(3.3)

$

(4.1)

Investment gains (losses), net

 

(50.5)

 

13.3

Other non-operating income (expenses), net

 

32.2

 

(3.9)

Income tax benefit (provision)

 

68.8

 

(29.9)

Interest expense

Interest expense decreased $0.8 million during the three months ended March 31, 2020, compared to the three months ended March 31, 2019, primarily due to a decrease in the unwind of the discount related to Geneva contingent consideration. Additionally, the three months ended March 31, 2019, also included interest expense in relation to the Perennial Fixed Interest Partners Ltd and Perennial Growth Management Pty Ltd (together “Perennial”) earn-out, which was fully paid during the year ended December 31, 2019.

Investment gains (losses), net

The components of investment gains (losses), net for the three months ended March 31, 2020 and 2019, were as follows (in millions):

Three months ended

March 31, 

    

2020

    

2019

Investment gains (losses), net (in millions):

 

  

 

  

Seeded investment products and derivatives, net

$

(43.5)

$

8.2

Other

 

(7.0)

 

5.1

Investment gains (losses), net

$

(50.5)

$

13.3

32

Investment gains (losses), net moved unfavorably by $63.8 million during the three months ended March 31, 2020, compared to the three months ended March 31, 2019, primarily due to fair value adjustments in relation to our seeded investment products and derivative instruments.

Other non-operating income (expenses), net

Other non-operating income (expenses), net improved $36.1 million during the three months ended March 31, 2020, compared to the three months ended March 31, 2019. The increase was primarily due to a $17.4 million gain and $7.1 million contingent consideration adjustment in relation to the sale of Geneva during the three months ended March 31, 2020. Favorable foreign currency translation of $12.1 million also contributed to the increase.

Income tax benefit (provision)

Our effective tax rates for the three months ended March 31, 2020 and 2019, were as follows:

Three months ended

March 31, 

    

2020

    

2019

Effective tax rate

19.4

%  

23.0

%

The effective tax rate for the three months ended March 31, 2020, compared to the three months ended March 31, 2019 was impacted by a significant reduction in pre-tax book income, resulting in a pre-tax book loss from impairment of intangible assets and goodwill, used to compute the effective tax rate. Most of the impairment charges were temporary in nature and did not have a direct impact on the effective tax rate. The change in the effective tax rate was primarily due to an increase in provision of income taxes attributable to non-controlling interests, a tax shortfall on non-deductible equity-based compensation and non-deductible goodwill. 

Non-GAAP Financial Measures

We report our financial results in accordance with GAAP. However, JHG management evaluates our profitability and our ongoing operations using additional non-GAAP financial measures. These measures are not in accordance with, or a substitute for, GAAP, and our financial measures may be different from non-GAAP financial measures used by other companies. Management uses these performance measures to evaluate the business, and adjusted values are consistent with internal management reporting. We have provided a reconciliation below of our non-GAAP financial measures to the most directly comparable GAAP measures.

33

Alternative performance measures

The following is a reconciliation of revenue, operating expenses, operating income (loss), net income (loss) attributable to JHG and diluted earnings (loss) per share to adjusted revenue, adjusted operating expenses, adjusted operating income, adjusted net income attributable to JHG and adjusted diluted earnings per share, respectively, for the three months ended March 31, 2020 and 2019 (in millions, except per share and operating margin data):

    

Three months ended

Three months ended

 

March 31, 

March 31, 

    

2020

2019

Reconciliation of revenue to adjusted revenue

 

  

  

Revenue

$

554.9

$

519.3

Management fees

(44.1)

(49.6)

Shareowner servicing fees

(41.1)

(27.2)

Other revenue

 

(27.0)

 

(25.1)

Adjusted revenue(1)

$

442.7

$

417.4

Reconciliation of operating expenses to adjusted operating expenses

 

  

 

  

Operating expenses

$

887.3

$

394.8

Employee compensation and benefits(2)

 

(1.4)

 

(4.3)

Long-term incentive plans(2)

 

0.1

 

0.2

Distribution expenses(1)

(112.2)

(101.9)

General, administrative and occupancy(2)

 

(1.9)

 

(7.4)

Impairment of goodwill and intangible assets(3)

(487.3)

Depreciation and amortization(3)

 

(6.4)

 

(7.4)

Adjusted operating expenses

$

278.2

$

274.0

Adjusted operating income

164.5

143.4

Operating margin(4)

 

(59.9%)

 

24.0%

Adjusted operating margin(5)

 

37.2%

 

34.4%

Reconciliation of net income (loss) attributable to JHG to adjusted net income attributable to JHG

 

  

 

  

Net income (loss) attributable to JHG

$

(247.0)

$

94.1

Employee compensation and benefits(2)

 

1.4

 

4.3

Long-term incentive plans(2)

 

(0.1)

 

(0.2)

General, administrative and occupancy(2)

 

1.9

 

7.4

Impairment of goodwill and intangible assets(3)

487.3

Depreciation and amortization(3)

 

6.4

 

7.4

Interest expense(6)

 

0.1

 

0.9

Other non-operating income (expenses), net(6)

 

(25.9)

 

0.4

Income tax benefit (provision)(7)

 

(111.4)

 

(4.3)

Adjusted net income attributable to JHG

 

112.7

 

110.0

Less: allocation of earnings to participating stock-based awards

 

(3.2)

 

(2.8)

Adjusted net income attributable to JHG common shareholders

$

109.5

$

107.2

Weighted-average common shares outstanding — diluted (two class)

 

182.4

 

192.5

Diluted earnings (loss) per share (two class)(8)

$

(1.35)

$

0.48

Adjusted diluted earnings per share (two class)(9)

$

0.60

$

0.56

(1)We contract with third-party intermediaries to distribute and service certain of our investment products. Fees for distribution and servicing related activities are either provided for separately in an investment product’s prospectus or are part of the management fee. Under both arrangements, the fees are collected by us and passed through to

34

third-party intermediaries who are responsible for performing the applicable services. The majority of distribution and servicing fees we collect are passed through to third-party intermediaries. JHG management believes that the reduction of distribution and servicing fees from revenue in the computation of adjusted revenue reflects the pass-through nature of these revenues. In certain arrangements, we perform the distribution and servicing activities and retain the applicable fee. Revenues for distribution and servicing activities performed by us are not deducted from GAAP revenue.

(2)Adjustments primarily represent integration costs in relation to the Merger, including severance costs, legal costs and consulting fees. Adjustments for the three months ended March 31, 2019, also include an impairment of sub-leased office space. JHG management believes these costs are not representative of our ongoing operations.

(3)Investment management contracts have been identified as a separately identifiable intangible asset arising on the acquisition of subsidiaries and businesses. Such contracts are recognized at the net present value of the expected future cash flows arising from the contracts at the date of acquisition. For segregated mandate contracts, the intangible asset is amortized on a straight-line basis over the expected life of the contracts. Adjustments for the three months ended March 31, 2020, also include impairment charges of our goodwill and certain mutual fund investment management agreements and client relationships. JHG management believes these non-cash and acquisition-related costs are not representative of our ongoing operations.

(4)Operating margin is operating income (loss) divided by revenue.

(5)Adjusted operating margin is adjusted operating income divided by adjusted revenue.

(6)Adjustments for the three months ended March 31, 2020, primarily relate to the gain recognized on the disposal of Geneva during the quarter. Other adjustments include contingent consideration adjustments associated with prior acquisitions and increased debt expense as a consequence of the fair value uplift on debt due to acquisition accounting. JHG management believes these costs are not representative of our ongoing operations.

(7)The tax impact of the adjustments is calculated based on the applicable U.S. or foreign statutory tax rate as it relates to each adjustment. Certain adjustments are either not taxable or not tax-deductible.

(8)Diluted earnings (loss) per share is net income (loss) attributable to JHG common shareholders divided by weighted-average diluted common shares outstanding.

(9)Adjusted diluted earnings per share is adjusted net income attributable to JHG common shareholders divided by weighted-average diluted common shares outstanding.

LIQUIDITY AND CAPITAL RESOURCES

Our capital structure, together with available cash balances, cash flows generated from operations, and further capital and credit market activities, if necessary, should provide us with sufficient resources to meet present and future cash needs, including operating and other obligations as they fall due and anticipated future capital requirements.

The following table summarizes key balance sheet data relating to our liquidity and capital resources as of March 31, 2020, and December 31, 2019 (in millions):

March 31, 

December 31, 

    

2020

    

2019

Cash and cash equivalents held by the Group

$

726.8

$

732.4

Investment securities held by the Group

$

197.9

$

223.6

Fees and other receivables

$

291.3

$

334.8

Debt

$

315.5

$

316.2

35

Cash and cash equivalents consist primarily of cash at banks and in money market funds. Cash and cash equivalents and investment securities held by consolidated VIEs and VREs are not available for general corporate purposes and have been excluded from the table above.

Investment securities held by us represent seeded investment products (exclusive of investments held by consolidated VIEs and VREs), investments related to deferred compensation plans and other less significant investments.

We believe that existing cash and cash from operations should be sufficient to satisfy our short-term capital requirements. Expected short-term uses of cash include ordinary operating expenditures, seed capital investments, interest expense, dividend payments, income tax payments and common stock repurchases. We may also use available cash for other general corporate purposes and acquisitions.

Regulatory Capital

We are subject to regulatory oversight by the SEC, the Financial Industry Regulatory Authority (“FINRA”), the U.S. Commodity Futures Trading Commission (“CFTC”), the Financial Conduct Authority (“FCA”) and other international regulatory bodies. We ensure that we are compliant with our regulatory obligations at all times. Our primary capital requirement relates to the FCA-supervised regulatory group (a sub-group of our company), comprising Henderson Group Holdings Asset Management Limited, all of its subsidiaries and Janus Capital International Limited (“JCIL”). JCIL is included to meet the requirements of certain regulations under the Banking Consolidation Directive. The combined capital requirement is £336.2 million ($416.9 million), resulting in capital above the regulatory group’s regulatory requirement of £182.6 million ($226.4 million) as of March 31, 2020, based on internal calculations and taking into account the effect of dividends related to first quarter 2020 results that will be paid in the second quarter 2020. Capital requirements in other jurisdictions are not significant.

Short-Term Liquidity and Capital Resources

Common Stock Repurchases

On February 3, 2020, the Board approved a new on-market share buyback program pursuant to which we are authorized to repurchase up to $200 million of our common stock on the NYSE and CDIs on the ASX at any time prior to the date of our 2021 Annual General Meeting. Repurchases pursuant to the buyback program after the date of our Annual General Meeting to be held on April 30, 2020, will be subject to our obtaining renewed shareholder authorization for on-market purchases at the 2020 Annual General Meeting. We commenced repurchases under the buyback program in March 2020 and repurchased a total of 2,061,205 shares of our common stock and CDIs for $31.2 million during the three months ended March 31, 2020.

Some of our executives and employees receive rights over our common stock as part of their remuneration arrangements and employee entitlements. These entitlements are usually satisfied by the transfer of existing common stock acquired on-market. We purchased 1,708,963 shares at an average price of $24.42 in satisfaction of employee awards and entitlements during the three months ended March 31, 2020.

Dividends

The payment of cash dividends is within the discretion of our Board of Directors and depends on many factors, including our results of operations, financial condition, capital requirements, general business conditions and legal requirements.

36

Dividends declared and paid during the three months ended March 31, 2020, were as follows:

Dividend

Date

Dividends paid

Date

per share

    

declared

(in US$ millions)

    

paid

$

0.36

February 3, 2020

 

$

66.2

March 5, 2020

On April 29, 2020, our Board of Directors declared a cash dividend of $0.36 per share. The quarterly dividend will be paid on May 27, 2020, to shareholders of record at the close of business on May 11, 2020.

Long-Term Liquidity and Capital Resources

Expected long-term commitments as of March 31, 2020, include principal and interest payments related to the 2025 Senior Notes, operating and finance lease payments, Intech senior profits interests awards, Intech appreciation rights and phantom interests, and Intech noncontrolling interests. We expect to fund our long-term commitments with existing cash, and cash generated from operations or by accessing capital and credit markets as necessary.

2025 Senior Notes

The 2025 Senior Notes have a principal amount of $300.0 million, pay interest at 4.875% semiannually on February 1 and August 1 of each year, and mature on August 1, 2025.

Intech

Intech has granted long-term incentive awards to retain and incentivize employees. The awards consist of appreciation rights, profits interests and phantom interests, and are designed to give recipients an equity-like stake in Intech. The grant date fair value of the appreciation rights is amortized using a graded basis over the 10-year vesting period. The awards are exercisable upon termination of employment from Intech to the extent vested. The profits interests and phantom interests awards entitle recipients to 9.1% of Intech’s pre-incentive profits.

37

Defined Benefit Pension Plan

The latest triennial valuation of our defined benefit pension plan resulted in a surplus of £12.0 million ($14.9 million).

We believe that we will have sufficient resources to satisfy our long-term liquidity requirements.

Off-Balance Sheet Arrangements

We are not party to any off-balance sheet arrangements that may provide, or require us to provide, financing, liquidity, market or credit risk support that are not reflected in our condensed consolidated financial statements.

Other Sources of Liquidity

At March 31, 2020, we had a $200 million Credit Facility. The Credit Facility includes an option for us to request an increase to the overall amount of the Credit Facility of up to an additional $50.0 million. The maturity date of the Credit Facility is February 16, 2024.

The Credit Facility may be used for general corporate purposes and bears interest on borrowings outstanding at the relevant interbank offer rate plus a spread.

The Credit Facility contains a financial covenant with respect to leverage. The financing leverage ratio cannot exceed 3.00x EBITDA. At the latest practicable date before the date of this report, we were in compliance with all covenants and there were no borrowings under the Credit Facility.

Cash Flows

A summary of cash flow data for the three months ended March 31, 2020 and 2019, was as follows (in millions):

 

Three months ended

March 31, 

    

2020

    

2019

Cash flows provided by (used for):

 

  

 

  

Operating activities

$

37.9

$

(34.7)

Investing activities

 

41.8

 

51.3

Financing activities

 

(46.0)

 

(198.3)

Effect of exchange rate changes on cash and cash equivalents

 

(28.0)

 

5.0

Net change in cash and cash equivalents

 

5.7

 

(176.7)

Cash balance at beginning of period

 

796.5

 

916.6

Cash balance at end of period

$

802.2

$

739.9

Operating Activities

Fluctuations in operating cash flows are attributable to changes in net income and working capital items, which can vary from period to period based on the amount and timing of cash receipts and payments.

38

Investing Activities

Cash provided by investing activities for the three months ended March 31, 2020 and 2019, was as follows (in millions):

 

Three months ended

March 31, 

    

2020

    

2019

Sales of investment securities, net

$

98.3

$

19.3

Sales (purchases) of investment securities by consolidated seeded investment products, net

(105.3)

46.1

Purchase of property, equipment and software

 

(8.2)

 

(7.5)

Proceeds from sale of Geneva

38.6

Cash received (paid) on settled hedges, net

17.9

(7.4)

Other

 

0.5

 

0.8

Cash provided by investing activities

$

41.8

$

51.3

Cash inflows from investing activities were $41.8 million and $51.3 million during the three months ended March 31, 2020 and 2019, respectively. Cash inflows from investing activities during the three months ended March 31, 2020, was primarily due to net sales of investment securities and proceeds from the sale of Geneva, partially offset by net purchases of investment securities by consolidated seeded investment products. When comparing the three months ended March 31, 2020, to the three months ended March 31, 2019, the change in cash provided by investing activities is primarily due to sales and purchases of investment securities by consolidated seeded investment products. An increase in third-party activity within the consolidated seeded investment products, primarily due to a larger VIE investment securities balance, which increased from $297.4 million at March 31, 2019, to $548.8 million at March 31, 2020, contributed to this change.

Financing Activities

Cash used for financing activities for the three months ended March 31, 2020 and 2019, was as follows (in millions):

 

Three months ended

March 31, 

    

2020

    

2019

Dividends paid to shareholders

$

(66.2)

$

(69.7)

Third-party sales (redemptions) in consolidated seeded investment products, net

 

105.3

 

(46.1)

Purchase of common stock for stock-based compensation plans

 

(39.8)

 

(37.1)

Purchase of common stock as part of share buyback program

 

(31.2)

 

(30.9)

Payment of contingent consideration

(13.8)

(14.1)

Other

 

(0.3)

 

(0.4)

Cash used for financing activities

$

(46.0)

$

(198.3)

Cash outflows from financing activities were $46.0 million and $198.3 million during the three months ended March 31, 2020 and 2019, respectively. Cash outflows during the three months ended March 31, 2020, were primarily due to dividends paid to shareholders and the purchase of common stock for stock-based compensation plans and the share buyback program, partially offset by net sales in consolidated seeded investment products. When comparing the three months ended March 31, 2020, to the three months ended March 31, 2019, the change in cash used for financing activities is primarily due to sales and purchases of securities within consolidated seeded investment products. An increase in third-party activity within the consolidated seeded investment products, primarily due to a larger VIE investment securities balance, which increased from $297.4 million at March 31, 2019, to $548.8 million at March 31, 2020, contributed to this change.

39

Item 3.   Quantitative and Qualitative Disclosures About Market Risk

There were no material changes in our exposure to market risks from that previously reported in our Annual Report on Form 10-K for the year ended December 31, 2019.

Item 4.   Controls and Procedures

As of March 31, 2020, our management evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Disclosure controls and procedures are designed by us to ensure that we record, process, summarize and report within the time periods specified in the SEC’s rule and forms the information we must disclose in reports that we file with or submit to the SEC. Richard M. Weil, CEO, and Roger Thompson, Chief Financial Officer, reviewed and participated in management’s evaluation of the disclosure controls and procedures. Based on this evaluation, Mr. Weil and Mr. Thompson concluded that as of the date of their evaluation, our disclosure controls and procedures were effective.

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the first quarter of 2020 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

Item 1.    Legal Proceedings

See Part I, Item 1. Financial Statements, Note 14 — Commitments and Contingencies.

Item 1A.  Risk Factors

Changes in our risk factors from those previously reported in our Annual Report on Form 10-K for the year ended December 31, 2019, are listed below.

Our results of operations have been, and will likely continue to be, adversely affected by the COVID-19 pandemic. 

The COVID-19 pandemic has severely impacted, and will likely continue to severely impact, global economic conditions, resulting in substantial volatility in the global financial markets; increased unemployment; and operational challenges such as the temporary closures of businesses and increased remote work protocols. Governments and central banks around the world have reacted to the economic crisis caused by the pandemic by implementing sheltering-in-place directives, stimulus and liquidity programs, and cutting interest rates, though it is unclear whether these or future actions will be successful in countering the economic disruption caused by COVID-19. If the pandemic is prolonged or the actions of governments and central banks are unsuccessful, the adverse impact on the global economy could deepen, and our results of operations and financial condition in future quarters also could be adversely affected. 

Towards the end of the first quarter of 2020 and into April 2020, the pandemic impacted our business and results of operations, and such impact could be greater in future quarters if conditions persist (e.g., widespread illness, quarantines, cancellation of events and travel, business and school shutdowns, supply chain disruptions, reductions in business activity, elevated levels of unemployment, and overall economic and financial market instability). Material impacts on our business may be possible, including the following:

Further decreases in revenues resulting from a decline in our AUM, the value and composition of which have been negatively impacted by the significant decline in the global financial markets;
Further decreases in AUM and increases in expenses resulting from volatility in foreign currency exchange rates, which directly impact our revenue and expenses as well as the valuation of our assets and liabilities denominated in foreign currencies;

40

Additional impairments in the value of intangible assets and goodwill on our balance sheet due to further declines in our AUM and continuing economic uncertainty caused by COVID-19;
Possible constraints on liquidity and capital, whether due to further decreases in revenues, further impairment charges or regulatory actions; and
Possible disruption of our business operations if our business continuity plan and the measures we have put in place to continue operations during the pandemic are not effective or are not sustainable over time.

The extent to which COVID-19 and the related global economic crisis affects our business, results of operations, and liquidity and financial condition, will depend on future developments that are highly uncertain and cannot be predicted, including the scope and duration of the pandemic and any recovery period; future actions taken by governmental authorities, central banks and other third parties in response to the pandemic; and the effects on our clients, counterparties, employees and third-party service providers. Moreover, the effects of the pandemic could have an impact on many of the other risks described in the section entitled “Risk Factors” in our most recent Annual Report on Form 10-K and any subsequent Quarterly Report on Form 10-Q or Current Report on Form 8-K.

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

Common Stock Purchases

On February 3, 2020, the Board approved a new on-market share buyback program pursuant to which we are authorized to repurchase up to $200 million of our common stock on the NYSE and CDIs on the ASX at any time prior to the date of our 2021 Annual General Meeting. Repurchases pursuant to the buyback program after the date of our Annual General Meeting to be held on April 30, 2020, will be subject to our obtaining renewed shareholder authorization for on-market purchases at the 2020 Annual General Meeting. We commenced repurchases under the buyback program in March 2020 and repurchased a total of 2,061,205 shares of our common stock and CDIs for $31.2 million during the three months ended March 31, 2020.

During the first quarter 2020, we purchased 1,708,963 shares on-market for $41.7 million for the annual share grants associated with the 2019 variable compensation, which was not related to the above Board approval.

The following table presents our ordinary shares purchased on-market by month during the three months ended March 31, 2020, in connection with the share buyback program and in satisfaction of employee awards and entitlements.

    

Total

    

    

Total number of shares

    

Approximate U.S. dollar value

number of

Average

purchased as part of

of shares that may yet

shares

price paid per

publicly announced

be purchased under the

Period

purchased

share

programs

programs (end of month, in millions)

January

 

5,000

$

25.28

 

 

$

February

 

1,550,760

 

25.02

 

 

$

200

March

 

2,214,408

 

15.34

 

2,061,205

 

$

168

Total

 

3,770,168

$

19.34

 

2,061,205

 

  

Items 3, 4 and 5.

Not applicable.

41

Item 6.    Exhibits

Filed with this Report:

Exhibit
No.

    

Document

    

Regulation S-K
Item 601(b)
Exhibit No.

15.1

Letter regarding unaudited interim financial information is attached to this Quarterly Report on Form 10-Q as Exhibit 15.1

15

31.1

Certification of Richard M. Weil, Chief Executive Officer of Registrant

31

31.2

Certification of Roger Thompson, Chief Financial Officer of Registrant

31

32.1

Certification of Richard M. Weil, Chief Executive Officer of Registrant, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32

32.2

Certification of Roger Thompson, Chief Financial Officer of Registrant, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32

101.INS

XBRL Instance Document — the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

101

101.SCH

XBRL Taxonomy Extension Schema Document

101

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

101

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

101

101.LAB

XBRL Taxonomy Extension Label Linkbase Document

101

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

101

104

Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document)

104

42

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: April 30, 2020

Janus Henderson Group plc

/s/ Richard M. Weil

Richard M. Weil,

Director and Chief Executive Officer

(Principal Executive Officer)

/s/ Roger Thompson

Roger Thompson,

Chief Financial Officer

(Principal Financial Officer)

/s/ Brennan A. Hughes

Brennan A. Hughes,

Senior Vice President,

Chief Accounting Officer and Treasurer

(Principal Accounting Officer)

43


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
8/1/25
2/16/24
1/1/21
12/31/20
5/27/20
5/11/20SC 13G/A
Filed on:4/30/208-K
4/29/208-K
4/27/20SC 13D/A
4/23/20
4/14/20
4/1/20
For Period end:3/31/2013F-HR
3/27/20
3/17/20
3/5/208-K
2/26/2010-K
2/3/20
1/31/20
1/2/20
1/1/20
12/31/1910-K,  11-K,  13F-HR
12/3/19
9/26/19
9/25/19
8/22/19
3/31/1910-Q,  13F-HR
3/29/19
2/7/19
1/31/19
1/1/19
8/20/18
5/4/188-K
4/17/18
3/31/1810-Q,  13F-HR
3/15/18
2/5/18
1/31/18
1/29/18
5/30/178-K
4/1/17
1/31/17
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/05/21  Janus Henderson Group plc         424B5                  1:929K                                   Toppan Merrill/FA
 2/04/21  Janus Henderson Group plc         424B3                  1:922K                                   Toppan Merrill/FA
 2/04/21  Janus Henderson Group plc         S-3ASR      2/04/21    9:1.5M                                   Toppan Merrill/FA
Top
Filing Submission 0001558370-20-004715   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 9, 8:49:28.2pm ET